From owner-diagnostics@net.bio.net Sat Jun 01 23:00:00 1996 Path: biosci!bcm.tmc.edu!cs.utexas.edu!howland.reston.ans.net!news-e2a.gnn.com!newstf01.news.aol.com!newsbf02.news.aol.com!not-for-mail From: rmeader726@aol.com (RMeader726) Newsgroups: bionet.diagnostics Subject: Dr Meader's mailing list Date: 1 Jun 1996 23:28:50 -0400 Organization: America Online, Inc. (1-800-827-6364) Lines: 8 Sender: root@newsbf02.news.aol.com Message-ID: <4or1pi$i25@newsbf02.news.aol.com> Reply-To: rmeader726@aol.com (RMeader726) NNTP-Posting-Host: newsbf02.mail.aol.com Doctors/Nurses/Pas/Students, Remind4 medical diagnosis software has been renamed DiagnosisPro. Email me for details/info and reprint of review article on Remind4 that appeared in Medical Software Reviews Journal, July 1995. Charles Meader, MD at 'Cmeader@mv.mv.com' or 'Rmeader726@aol.com' We now have a home page as well: http://home.aol.com/Rmeader726 Get on our mailing list....no strings. From owner-diagnostics@net.bio.net Sat Jun 01 23:00:00 1996 Path: biosci!agate!howland.reston.ans.net!EU.net!usenet1.news.uk.psi.net!uknet!dist.news.psi.net!psinntp!interramp.com!usenet From: LEE Newsgroups: bionet.diagnostics Subject: Job Opening Date: Sat, 01 Jun 1996 18:54:33 -0700 Organization: PSI Public Usenet Link Lines: 6 Message-ID: <31B0F459.622B@interramp.com> NNTP-Posting-Host: 38.10.225.134 Mime-Version: 1.0 Content-Type: text/plain; charset=us-ascii Content-Transfer-Encoding: 7bit X-Mailer: Mozilla 2.01 (Win16; I) Immunodiagnostic manufacturer looking for PhD level researchers with a > background in lateral flow membrane based assay development. > Familliarity with gold reagents, protein immobilization and assay > optimization. Industry experience necessary. Masters level applicants > considered. Fax resume to 516 924-6033 (or email > ir002012@interramp.com) From owner-diagnostics@net.bio.net Sat Jun 01 23:00:00 1996 Path: biosci!daresbury!not-for-mail From: Eduardo Perez Campos Newsgroups: bionet.diagnostics Subject: Maize lectin Date: 2 Jun 1996 19:19:27 +0100 Lines: 17 Sender: lpddist@mserv1.dl.ac.uk Distribution: bionet Message-ID: <4oslvf$4c4@mserv1.dl.ac.uk> MIME-Version: 1.0 X-Chameleon-Return-To: laborato@antequera.antequera.com Original-To: glycosci@net.bio.net, immuno@net.bio.net, diagnost@net.bio.net, diagnost@dl.ac.uk Dera neters: I am looking for NMR study collaboration. We have a new protein , is a new lectin from maize, we began to biochemical characterization and to test in coagulation model. Do you interest in it? Eduardo Eduardo Perez-Campos E-mail: laborato@antequera.antequera.com 06/01/96 19:57:18 From owner-diagnostics@net.bio.net Sun Jun 02 23:00:00 1996 Path: biosci!bcm.tmc.edu!cs.utexas.edu!howland.reston.ans.net!news-e2a.gnn.com!newstf01.news.aol.com!newsbf02.news.aol.com!not-for-mail From: sky406@aol.com (Sky406) Newsgroups: bionet.diagnostics Subject: CHEMISTS-Immediate Openings Date: 2 Jun 1996 20:44:32 -0400 Organization: America Online, Inc. (1-800-827-6364) Lines: 33 Sender: root@newsbf02.news.aol.com Message-ID: <4otchg$a5n@newsbf02.news.aol.com> Reply-To: sky406@aol.com (Sky406) NNTP-Posting-Host: newsbf02.mail.aol.com National Diagnostics, an international biotechnology company based in Atlanta, Georgia, is currently seeking chemists for the following positions: Ph.D. The preferred candidate will have a Ph.D. in synthetic organic chemistry with emphasis in the production and development of reagents useful to the field of molecular biology. Particular experience in electrophoretic biopolymer separations, cross-linking proteins, and luminescent labels would facilitate assimilation into the existing technical development team. Creative intellectual environment. Bench/large glassware (12-22 L) experience necessary. Three to four years post-doctoral or previous industrial experience required. The position will have responsibility for make/buy decisions, and the successful candidate should be capable of managing day to day operations, direct technicians, and provide insight and leadership for the company's vitality and future growth. Salary is commensurate with experience. Excellent benefits and the position is available immediately. MS Bench/large glassware experienced synthetic organic chemist. Good theoretical knowledge with literature research skills who can contribute to sonment. Salary is commensurate with experience. Excellent benefits, and the position is available immediately. Please send or fax resume to the attention of Ms. K. Hennesey at: National Diagnostics 305 Patton Drive Atlanta, GA 30336 fax: (404) 699-2077 From owner-diagnostics@net.bio.net Sun Jun 02 23:00:00 1996 Path: biosci!bcm.tmc.edu!cs.utexas.edu!chi-news.cic.net!news.compuserve.com!news.production.compuserve.com!news From: Survey Administration <74750.1341@CompuServe.COM> Newsgroups: bionet.cellbiol,bionet.cellbiol.cytonet,bionet.diagnostics Subject: WE NEED YOUR INPUT Date: 3 Jun 1996 03:14:44 GMT Organization: Kitty Knight Corporation Lines: 25 Message-ID: <4otlb4$3ni$2@mhade.production.compuserve.com> Xref: biosci bionet.cellbiol:4833 bionet.cellbiol.cytonet:562 bionet.diagnostics:845 Please excuse this brief intrusion, but we are trying to locate any and all holders of academic degrees conferred within the last ten (10) years. The Kitty Knight Corporation, Boston, MA, is currently searching for qualified individuals to participate in a ***PAID*** study focusing on post-secondary, graduate, and professional education in the United States. Holders of ALL types of degrees in ALL fields of study are needed. We would like to hear from you as long as your degree was earned at an accredited institution in the United States. After an initial screening, qualified participant will be asked to complete a questionaire of approx 150 questions. Everyone who completes the survey will receive a $100 stipend. Naturally, *ALL* information will be held in the strictest confidence. To express interest, please send your name, mailing address, and photocopies of **ALL** degrees you have earned to: The Kitty Knight Corporation, Attn: Study 96-3H, Back Bay Annex, P O Box 546, Boston, MA 02117. (If not obvious from the degree, please indicate the field of study.) Thank You Very Much! From owner-diagnostics@net.bio.net Sun Jun 02 23:00:00 1996 Path: biosci!biosci!not-for-mail From: Bernhard Pflesser Newsgroups: bionet.software,bionet.biology.cardiovascular,bionet.diagnostics,bionet.general,bionet.neuroscience Subject: VBC96--CALL FOR PARTICIPATION Date: 3 Jun 1996 11:12:15 -0700 Organization: University Hospital Eppendorf / Hamburg Lines: 196 Sender: daemon@net.bio.net Distribution: world Message-ID: References: NNTP-Posting-Host: net.bio.net Xref: biosci bionet.software:15680 bionet.biology.cardiovascular:1012 bionet.diagnostics:848 bionet.general:21973 bionet.neuroscience:14413 -------------------------------------------------------------------- Fourth International Conference on VISUALIZATION IN BIOMEDICAL COMPUTING Sept. 22 - Sept. 25, 1996 Hamburg, Germany -------------------------------------------------------------------- CALL FOR PARTICIPATION The "Call for Participation" of VBC'96 is now available! Please visit our WWW-Page to find detailed information about the preliminary program, registration, social events and more: =================================== http://www.uke.uni-hamburg.de/vbc96 =================================== or contact us via: Institute of Mathematics and Computer Science in Medicine (IMDM) Department of Computer Science in Medicine Pav. 70 University Hospital Eppendorf Martinistrasse 52 D-20246 Hamburg Germany Phone : +49-40-4717 3652 Fax : +49-40-4717 4882 E-mail: vbc96@uke.uni-hamburg.de -------------------------------------------------------------------- Scope Following Georgia Tech, the University of North Carolina, and the Mayo Institutions, the University of Hamburg will host the 4th conference on Visualization in Biomedical Computing (VBC'96). Its goal is to enhance and promote the science of computer based visualization of biomedical information, especially about the various aspects of the human body. An interdisciplinary, international group of scientists, engineers, and clinicians will present and discuss the state of the art concerning algorithms, the rapidly increasing number of applications, and the practical problems of system design. ------------------------------------------------------------------------ Topics Theory and Algorithms Applications Systems * Models of * Diagnostics with * Hardware/Software Visualization MRI, CT, PET/SPECT, Tools * Rendering Algorithms MEG Ultrasound etc. * Interactive * Image Analysis * Microscopy Imaging Workstations and * Multi-Modality Image * Surgical and Networks Registration and Stereotactic * Virtual Reality User Fusion Planning Interfaces * Shape Description * Surgery Simulation * Novel Image and Characterization * Image Guided Acquisition Equipment * Spatial Knowledge Surgery * Special Processors Modeling * Endoscopy * Artificial Simulation Intelligence in * Radiation Visualization Treatment Planning * Visual Perception * Biomechanics and and Communication Orthopedics * Virtual / Augmented * Dentistry and Reality Paradigms Orthodontics * Prothetics Development * Modeling the human body (with emphasis on the brain) * Anatomy Atlases (with emphasis on VISIBLE HUMAN) * Medical and Biological Education ------------------------------------------------------------------------ Format According to the interdisciplinary nature of the conference, it has a single track of sessions with 25 minute papers. Posters and demonstrations will be located next to the auditorium. Tutorials will be held the day before the official opening (Sept. 22) as in the previous meetings. ------------------------------------------------------------------------ Proceedings Proceedings will be published in Lecture Notes in Computer Science, Springer Verlag Heidelberg-New York. They will be available at the time of the conference. ------------------------------------------------------------------------ Visits Visits to laboratories in Hamburg will be arranged for the day after the conference (IMDM, Philips Research, Dept. of Computer Science) ------------------------------------------------------------------------ Location University of Hamburg, main building, in walking distance to the city which surrounds the beautiful Alster lake. ------------------------------------------------------------------------ Previous Conferences 1990 Georgia Institute of Technology, Atlanta, GA Proceedings: First Conference on Visualization in Biomedical Computing, IEEE Computer Society Press, 1990 1992 University of North Carolina, Chapel Hill, NC Proceedings: Visualization in Biomedical Computing II, Proc. SPIE 1808, 1992 1994 Mayo Foundation, Rochester, MN Proceedings: Visualization in Biomedical Computing 1994, Proc. SPIE 2359, 1994 ------------------------------------------------------------------------ Conference Committee Chairman Karl Heinz Hoehne, University of Hamburg Program Committee Ron Kikinis (Chair), Harvard Medical School Nicholas Ayache, INRIA, Sophia-Antipolis Jean Louis Coatrieux, University of Rennes Takeyoshi Dohi, University of Tokyo James Duncan, Yale University Alan C. Evans, Montreal Neurological Inst. Norberto Ezquerra, Georgia Tech, Atlanta Henry Fuchs, UNC, Chapel Hill Guido Gerig, ETH Zuerich Eric Grimson, MIT, Cambridge David Hawkes, Guy's Hospital London Arie Kaufman, State University of New York Andres Kriete, University of Giessen Hal Kundel, University of Pennsylvania Heinz Lemke, Free University of Berlin David Levin, University of Chicago Heinrich Mueller, University of Dortmund Chuck Pelizzari, University of Chicago Stephen Pizer, UNC, Chapel Hill Richard Robb, Mayo Foundation / Clinic Siegfried Stiehl, University of Hamburg Paul Suetens, University of Leuven Andrew Todd-Pokropek, University College London Jun-Ichiro Toriwaki, Nagoya University Michael Vannier, Washington University, St Louis Max Viergever, Utrecht University Coordinators Bernhard Pflesser, Thomas Schiemann, Rainer Schubert, IMDM ------------------------------------------------------------------------ Supporting Organisations University of Hamburg The Institute of Electrical and Electronics Engineers (IEEE) German Society of Computer Science (GI) German Society of Medical Informatics, Biometrics, and Epidemiology (GMDS) e.V. ------------------------------------------------------------------------ From owner-diagnostics@net.bio.net Sun Jun 02 23:00:00 1996 Path: biosci!sasa.gov.uk!browning From: browning@sasa.gov.uk (Isla Browning) Newsgroups: bionet.diagnostics Subject: peroxidases Date: 3 Jun 1996 10:20:31 -0700 Organization: BIOSCI International Newsgroups for Molecular Biology Lines: 15 Sender: daemon@net.bio.net Distribution: world Message-ID: NNTP-Posting-Host: net.bio.net Hi! Can anyone tell me if peroxidases are present in significant quantities in plant tissue and does anyone know the thermal inactivation temperature of peroxidases? Isla Browning Diagnostics and Molecular Biology Section SASA East Craigs Edinburgh 3/6/96 From owner-diagnostics@net.bio.net Sun Jun 02 23:00:00 1996 Path: biosci!internet!biosci!not-for-mail From: biohelp (BIOSCI Administrator) Newsgroups: bionet.diagnostics Subject: IMPORTANT - BIOSCI Fundraising Update! Date: 3 Jun 1996 02:00:47 -0700 Organization: BIOSCI International Newsgroups for Molecular Biology Lines: 154 Sender: daemon@net.bio.net Distribution: world Message-ID: <199606030900.CAA27655@net.bio.net> NNTP-Posting-Host: net.bio.net BIOSCI is about halfway to its funding goal!! I'm interrupting the usual monthly posting of the BIOSCI miniFAQ to bring you up to date on BIOSCI fundraising progress, a topic of concern to your future use of this resource. Thank you in advance for taking the time to read this message carefully. Last year we announced that BIOSCI was going to adopt the U.S. Public Broadcasting System model to fund its operations after our DOE/NSF grant runs out later this year. Unlike PBS, we are not soliciting contributions from users; we are only selling ads on our Web pages solely to cover our operating costs. Our goal is to seek sponsorships until we build up an operating reserve of about $100,000 and then cease further promotions until we need to build the reserve back up. (The accountants among our readership will be familiar with the problem of deferred revenue which we can not safely utilize until ads have been displayed for a period of time.) We are only about halfway to our funding goal and need to raise further funds to avoid having to curtail services at net.bio.net. Fundraising is time-consuming, however, and we need your help as explained further below. Our operating costs consist of our network connection, phone lines, hardware maintenance (we will be getting newer and faster hardware soon!), plus 0.7 FTE of salaries covering UNIX systems admin, technical support, quality assurance, i.e., testing, of our system, and administrative costs (such as the time it takes to actually find/write/call potential sponsors and raise money!). Although the BIOSCI staff does get compensated for a portion of the work that they do, this project has always received a lot of free after-hours and "vacation" time labor, so we hope that no one will begrudge the time that we do charge to the project to serve you. All of the three part-time staff members, Dave Mack, Julie Lawrence, and myself, have full time day jobs and families in addition to working hard to keep this service running for all of you. Julie and Dave Mack are subcontractors for BIOSCI; my time that is charged to the project defrays a portion of my regular salary instead of adding to my income. Besides having to relocate the project, we were very busy this last year building new infrastructure such as our WWW hypermail interface to the system. This was released last December along with scores of WAIS indices for the newsgroups. Virtually everything is complete, although we do continue to find and fix bugs (many through your helpful feedback!). We are still having some problems with our WAIS indexing. The archives continue to grow rapidly. We are running over 100 indexes now versus three previously and any systems crashes cause greater havoc with the indexing than before! We are still working to fix this as fast as our resources permit and appreciate your patience, but we have been able to automate a lot of the infrastructure to reduce labor as compared to past requirements. We have also implemented new software to make moderation of BIOSCI/bionet newsgroups much easier and combat the growing problem of Internet junk mail and USENET "spamming." About 20% of our groups are now moderated, many of them by the BIOSCI staff! This, for example, made a major difference last year in the quality of content in our EMPLOYMENT/bionet.jobs.offered newsgroup which many commercial concerns and recruiting firms are using **without charge** to recruit candidates for positions in the biological sciences. We are also now in a position to have sponsors for individual newsgroups as you will have noticed if you have visited http://www.bio.net/ and clicked on "Access the BIOSCI/bionet newsgroups" recently. So, how can you help?? ---------------------- As noted above it can take a lot of time to contact potential sponsors if I have to do it all myself. Our request is quite simple. You can do two important things which will take very little time for you individually. First, please use our WWW system at http://www.bio.net/ to access the archives. You can now post or reply to messages via your Web browser. Your usage helps attract sponsors. If you contact any of our sponsors, please be sure to thank them for supporting BIOSCI. It is critical for them to get this feedback if they are to continue their sponsorship for the long term. Second, if you work for a company or organization that provides products or services of interest to the biology community, please pass this message on to your marketing or marketing communications department or other appropriate group. Please ask them to help support BIOSCI by sponsoring our Web site and explain the uses and benefits of the system to the biology community. If they are interested, they can then contact us for further information at our tech support address, biosci-help@net.bio.net. Our hope is to quickly raise several large corporate/institutional sponsors on our heavily-used WWW locations (some stats appended below), and then end this sponsorship campaign so that our resources can continue to be used for service provision, not fundraising. Many of our specialty newsgroup WWW archives are still used by small communities of scientists (and they haven't been heavily promoted yet). While these may be valuable niche markets to some advertisers, it will generate more labor and overhead having to find these sponsors, fairly price the locations, and deal with lots of smaller sponsorships than fewer mid-to large sponsors. We are striving to keep our operation as lean and efficient as possible since we are not trying to make careers out of running BIOSCI. We are trying if at all possible to avoid the administrative overhead entailed with processing lots of small payments to reach our fundraising goals. I'd like to thank all of you for your help in advance. In helping us, you are also helping yourselves, not only in keeping this resource available for all of the both large and small research communities that we serve, but also by alleviating the need for us to go back and compete with researchers for tight grant dollars! We promised NSF when we were awarded the BIOSCI grant that we would carry out this mission to make the service self-supporting. With your help, we will succeed in continuing BIOSCI's work into its second decade. Thank you very much! Sincerely, Dave Kristofferson BIOSCI/bionet Manager biosci-help@net.bio.net A list of our prime WWW sponsorship locations follow. Please contact us for further details. ---------------------------------------------------------------------- The overall BIOSCI WWW pages are currently visited by users from close to 5500 unique computer hosts per week. Web servers only log the Internet computer/host name and frequently more than one individual can connect to us from a particular host. Main home page, http://www.bio.net, visited recently by about 2100 unique hosts per week Main Newsgroups archives page, http://www.bio.net/archives.html, visited recently by about 1200 Unique hosts per week BIO-JOURNALS archive page, http://www.bio.net/BIO-JOURNALS.html, visited recently by about 1000 unique hosts per week. EMPLOYMENT archive pages: http://www.bio.net:80/hypermail/EMPLOYMENT/ and monthly header pages, visited recently by about 800 unique hosts per week. Address database search page, http://www.bio.net/addrsearch.html, visited recently by about 450 unique hosts per week. Methods newsgroup archive pages, http://www.bio.net:80/hypermail/METHDS- REAGNTS/ and monthly header pages, visited recently by about 350 unique hosts per week. Ads can also be displayed on various combinations of other BIOSCI/bionet newsgroups. Please contact us at biosci-help@net.bio.net for details. ---------------------------------------------------------------------- From owner-diagnostics@net.bio.net Sun Jun 02 23:00:00 1996 Path: biosci!AZUL.CTC.COM.BR!ctft-1-ulian From: ctft-1-ulian@AZUL.CTC.COM.BR (Eugenio Ulian) Newsgroups: bionet.diagnostics Subject: Re: commercial plant pathogen molecular diagnostics Date: 3 Jun 1996 16:50:29 -0700 Organization: Centro Tecnologia Copersucar Lines: 21 Sender: daemon@net.bio.net Distribution: world Message-ID: NNTP-Posting-Host: net.bio.net My company provides a diagnostic service for ratoon stunting disease of sugarcane using a polyclonal for the bacteria in dot blots. We process about 60,000 samples per year. If you want more information feel free to ask me. Regards, Eugenio Ulian xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx Eugenio Cesar Ulian Molecular Biology Section Copersucar Technology Center Caixa Postal 162 13400-970 Piracicaba Sao Paulo Brasil E-mail:ulian@azul.ctc.com.br Voice:0055194-29-8283 Fax:0055194-29-8388 xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx From owner-diagnostics@net.bio.net Mon Jun 03 23:00:00 1996 Path: biosci!sasa.gov.uk!odonnell From: odonnell@sasa.gov.uk ("Kevin O'Donnell") Newsgroups: bionet.diagnostics Subject: Commerical Posts Date: 4 Jun 1996 03:53:52 -0700 Organization: Scottish Agricultural Science Agency Lines: 75 Sender: daemon@net.bio.net Distribution: world Message-ID: <9606041148.aa06493@jura.sasa.gov.uk> Reply-To: odonnell@sasa.gov.uk NNTP-Posting-Host: net.bio.net A reminder of the Biosci/Bionet policy on commercial content of posts (taken from the Biosci FAQ at http://www.bio.net/biosci/biosci.faq.html) What are the restrictions on commercial activities in the BIOSCI/bionet newsgroups? BIOSCI is funded in part by the National Science Foundation (NSF) which supports the Internet in the U.S. with U.S. taxpayer dollars. NSF is responsible for setting Acceptable Use Policy (AUP) for the the NSFNet backbone section of the Internet of which BIOSCI makes extensive use. Because of these reasons, BIOSCI users should adhere to the following guidelines. Commercial activities on BIOSCI are in general prohibited except as noted below. People at for-profit organizations are free to read all postings made to the BIOSCI/bionet newsgroups, but must ensure that their postings to the newsgroups do not violate our guidelines. Commercial organizations may post job openings on EMPLOYMENT/bionet.jobs subject to the format restrictions for that group. Commercial job posting format restrictions for the EMPLOYMENT/bionet.jobs newsgroup are described above under the question "Where should I post my messages?" Users who violate these format restrictions consciously risk losing their network access. BIOSCI readers without any financial connections to a company or a product may discuss and/or post endorsements of a commercial product. However, it is standard Internet practice to include in the posting a disclaimer of any financial interest in the product/company. Note that postings to newsgroups are subject to libel laws. BIOSCI advises readers to think twice before taking potshots at products that they do not like. BIOSCI users often post general questions about problems that might be solved through the use of a commercial product. It is EXTREMELY IMPORTANT, however, that such general questions not be answered by people affiliated with the product or company that might stand to gain a sale as a result. For example, user X may ask, "Is there a product that will allow me to separate protein A from protein B given the following properties ...?", but, if user Y works at company Z which sells a product that can accomplish this task, user Y does NOT have permission to respond to the question. Responses can only be posted by other scientists who might have experience in solving the problem in question and who do not stand to gain financially by promoting the product in question, i.e., they are not employees, consultants, or connected to the company via other financial ties. As noted above, postings endorsing commercial products should contain a customary disclaimer stating the absence of financial ties of the poster to the product/company. Commercial companies MAY RESPOND to a public BIOSCI newsgroup if a BIOSCI user asks a question directly about one of their products, e.g., mentions it by name. The response should be limited to a factual answer of the question posed and should avoid any hint of advertising hype. Comparisons with competitors' products should be avoided completely. Finally, as a general rule, if you are unsure about the appropriateness of your posting, before you post anything please send a copy of what you propose to post to the BIOSCI adminstrator at biosci-help@net.bio.net for review. BIOSCI will takes steps to terminate network access to any reader who willfully violates our commercial use policies. Extract from FAQ ends. Dr Kevin O'Donnell "I'm happy, I'm happy Diagnostics and Molecular Biology and I'll punch the man that says I'm not" SASA - Ivor Cutler Edinburgh From owner-diagnostics@net.bio.net Mon Jun 03 23:00:00 1996 Path: biosci!usp.br!lpereira From: lpereira@usp.br (Lygia da Veiga Pereira) Newsgroups: bionet.diagnostics Subject: antibiotic resistance Date: 4 Jun 1996 05:02:59 -0700 Organization: BIOSCI International Newsgroups for Molecular Biology Lines: 8 Sender: daemon@net.bio.net Distribution: world Message-ID: NNTP-Posting-Host: net.bio.net Does anyone know of PCR based methods to determine antibiotic resistance of microorganisms? Thanks! Lygia V. Pereira, Ph.D. From owner-diagnostics@net.bio.net Mon Jun 03 23:00:00 1996 From: pbianchi@maxidata.it (Pietropaolo Bianchi) Newsgroups: bionet.diagnostics Subject: Re: looking for HDC Corp. Date: Sat, 01 Jun 1996 15:51:48 GMT Organization: Telnet - Italian Internet Provider Lines: 20 Message-ID: <4oplms$7ek@cleopatra.telnetwork.it> References: <960530115220_313981039@emout10.mail.aol.com> NNTP-Posting-Host: ppp-stradella-52.maxidata.it X-Newsreader: Forte Free Agent 1.0.82 Path: biosci!bcm.tmc.edu!news.msfc.nasa.gov!newsfeed.internetmci.com!in2.uu.net!tank.news.pipex.net!pipex!usenet1.news.uk.psi.net!uknet!EU.net!Norway.EU.net!nntp.uio.no!news.kth.se!eru.mt.luth.se!solace!news.sbbs.se!newsfeed.tip.net!peroni.ita.tip.net!cleopatra.telnetwork.it!usenet MHughes77@aol.com wrote: >Alex Chang asked: >>I am wondering anyone knows the HDC Corp., Mountain View, California. >>I am interested in their Entero-test kit. >For the information of others in the newsgroup, the Entero-test kit is a >noninvasive device for collecting H. pylori bacteria from patients with >stomach ulcers. This method is especially useful for monitoring the >effectiveness of antibiotic therapy. Also, I have used it several times for collecting trophozoites of giardia lamblia from duodenum. Gee, it does work! Ciao P. Bianchi MD From owner-diagnostics@net.bio.net Mon Jun 03 23:00:00 1996 Path: biosci!knoxy.agvic.gov.au!millerj From: millerj@knoxy.agvic.gov.au (James Miller) Newsgroups: bionet.diagnostics Subject: (Fwd) Re: commercial plant pathogen molecular diagnostics Date: 3 Jun 1996 20:37:05 -0700 Organization: Dept. of Agriculture (Vic). Lines: 60 Sender: daemon@net.bio.net Distribution: world Message-ID: NNTP-Posting-Host: net.bio.net ------- Forwarded Message Follows ------- Date: Fri, 17 May 1996 00:46:59 -0700 From: odonnell@sasa.gov.uk ("Kevin O'Donnell") Subject: Re: commercial plant pathogen molecular diagnostics To: diagnost@net.bio.net Reply-to: odonnell@sasa.gov.uk On 16 May 96 at 22:35, James Miller wrote: > > I am interested in gathering information about commercial molecular > diagnostics for plant pathogens. > As I understand there are many people researching and using molecular > diagnostics for plant pathogens around the world (specifically PCR > tests, dot blots, nucleic-acid based tests). > However, not many of these tests have been successfully integrated > into commercial services. > Is this indeed the case, and does anybody know of molecular tests for > plant pathogens that are currently being used in commercial > situations? A bit of a potato centric answer for you I'm afraid: I know of one company in the UK that uses dot blots to detect potato viruses in tubers. We (Scottish Agricultural Science Agency) use dot blots to detect potato spindle tuber viroid in potato plants received in our quarantine facility. PCR is routinely used in the EC for testing for Pseudomonas solanacearum (Brown Rot of potatoes) and Clavibacter michiganensis subsp. sepedonicus (Ring Rot of potatoes). There are also PCR-based tests for potato cyst nematode identification that are coming into routine use. If you get any replies by email, please repost the information here as this is a subject of interest to many of us. Hope this is helpful. Kevin Dr Kevin O'Donnell "I'm happy, I'm happy Diagnostics and Molecular Biology and I'll punch the man that says I'm not" SASA - Ivor Cutler Edinburgh *********************************************** James Miller Agriculture Victoria Institute for Horticultural Development Knoxfield Private Bag 15 South Eastern Mail Centre Victoria 3176 ****************************************** Ph-(03) 9210 9252 (o o) FAX- (03) 9800 3521 ( O ) **************************oOO*****OOo***** From owner-diagnostics@net.bio.net Mon Jun 03 23:00:00 1996 Path: biosci!knoxy.agvic.gov.au!millerj From: millerj@knoxy.agvic.gov.au (James Miller) Newsgroups: bionet.diagnostics Subject: (Fwd) Re: commercial plant pathogen molecular diagnostics Date: 3 Jun 1996 20:07:00 -0700 Organization: Dept. of Agriculture (Vic). Lines: 62 Sender: daemon@net.bio.net Distribution: world Message-ID: NNTP-Posting-Host: net.bio.net ------- Forwarded Message Follows ------- Date: Fri, 17 May 1996 08:04:12 -0500 (EST) From: Don Marti Subject: Re: commercial plant pathogen molecular diagnostics To: James Miller Dear Dr. Miller, This is in regard to your question on bionet.diagnostics regarding molecular testing technologies for plant pathogens. We at Agdia have several nucleic acid-based test systems for plant pathogens, including nucleic acid hybridization tests for potato spindle tuber viroid and chrysanthemum stunt viroid, and a PCR-based testing service for phytoplasmas (mycoplasma-like organisms). The hybridization tests are available either as a testing service or as a kit. Kit customers spot samples, then return membranes for processing. Phytoplasma testing is available as a testing service. To purchase Agdia testing products or send samples for testing, we have a distributor in Australia: TASAG ELISA and Pathogen Testing Service St. John's Avenue New Town, Tasmania 7008 AUSTRALIA Contact: Dr. Gradon R. Johnstone Telephone: (61) 02-784-325 Fax: (61) 02-782-716 In addition to the two systems that are commercially available, we are researching other molecular methods. We also collaborate extensively with government and university researchers who develop new testing technologies. If you have World Wide Web access, I hope that you will visit our WWW site: http://www.agdia.com for more information on the products and services we offer. And feel free to mail me with any questions on our products or services. Don Marti | | Agdia Incorporated dmarti@agdia.com | http://www.agdia.com | Elkhart, Indiana 219-264-2014 | | USA *********************************************** James Miller Agriculture Victoria Institute for Horticultural Development Knoxfield Private Bag 15 South Eastern Mail Centre Victoria 3176 ****************************************** Ph-(03) 9210 9252 (o o) FAX- (03) 9800 3521 ( O ) **************************oOO*****OOo***** From owner-diagnostics@net.bio.net Mon Jun 03 23:00:00 1996 Path: biosci!idbiomed.com!PeterD From: PeterD@idbiomed.com (Peter Duck) Newsgroups: bionet.diagnostics Subject: Cholera tests Date: 3 Jun 1996 18:12:41 -0700 Organization: BIOSCI International Newsgroups for Molecular Biology Lines: 20 Sender: daemon@net.bio.net Distribution: world Message-ID: <31B38CB1@mailbox.electric.net> NNTP-Posting-Host: net.bio.net Try New Horizons Diagnostics in Columbia, MD. Tel. # (410) 992-9357. Good Luck, Peter Duck ---------- From: BIOSCI-REQUEST To: diagnost Subject: Seeking Cholera Tests Date: Wednesday, May 29, 1996 12:36PM Bionet Diagnostics newsgroup members: I am seeking a manufacturer of rapid immunotests for diagnosing Cholera. Any leads, as well as comments regarding the accuracy of these tests, would be greatly appreciated. Mark Hughes From owner-diagnostics@net.bio.net Mon Jun 03 23:00:00 1996 Path: biosci!sasa.gov.uk!odonnell From: odonnell@sasa.gov.uk ("Kevin O'Donnell") Newsgroups: bionet.diagnostics Subject: Charter for bionet.diagnostics Date: 4 Jun 1996 03:53:52 -0700 Organization: Scottish Agricultural Science Agency Lines: 54 Sender: daemon@net.bio.net Distribution: world Message-ID: <9606041148.aa06497@jura.sasa.gov.uk> Reply-To: odonnell@sasa.gov.uk NNTP-Posting-Host: net.bio.net This is a periodic reposting of the charter for the bionet.diagnostics newsgroup and mailing list Information for DIAGNOSTICS/bionet.diagnostics USENET name: bionet.diagnostics (unmoderated) Mailing list name: DIAGNOSTICS Email addresses: diagnost@net.bio.net diagnost@daresbury.ac.uk Discussion leaders: Kevin O'Donnell (odonnell@sasa.gov.uk) Robert Burns (antibodies) (burns@sasa.gov.uk) Newsgroup Charter: The DIAGNOSTICS newsgroup (bionet.diagnostics) is a forum for discussion of problems and techniques (primarily serological or nucleic acid-based) involved in all fields of diagnostics. Subjects for discussion and comment include methodology, automation, quality assurance and other subjects of interest and concern to those developing and/or using diagnostic tests. Justification Despite the large number of scientists involved in diagnostics, there is no newsgroup devoted to this subject. The prototype DIAGNOSTICS newsgroup was set up to fill this gap and has gained enough support to justify a vote for full newsgroup status. The prototype newsgroup has included postings on the detection and identification of diseases, pathogens (animal and plant) and also diagnostic functions which do not fit into either category. This composition has helped to establish common ground (and therefore intellectual and methodological cross-fertilization) between people and laboratories. For example, the problems facing scientists developing PCR assays for Listeria are similar to those facing scientists developing PCR assays for bacterial soft rots in plants. Within the various disciplines there are common problems regarding methods, immunogens, cross-reactivity, automation, materials, quality assurance and other issues that are not recognized by those using similar techniques for other purposes. The DIAGNOSTICS newsgroup will address and help solve these problems by providing a forum for their discussion between individuals of various experience and disciplines Dr Kevin O'Donnell "I'm happy, I'm happy Diagnostics and Molecular Biology and I'll punch the man that says I'm not" SASA - Ivor Cutler Edinburgh From owner-diagnostics@net.bio.net Mon Jun 03 23:00:00 1996 Path: biosci!EM.AGR.CA!DEBOERS From: DEBOERS@EM.AGR.CA (Solke Deboer) Newsgroups: bionet.diagnostics Subject: Commercial PP Molecular Diagnostics Date: 4 Jun 1996 09:18:41 -0700 Organization: BIOSCI International Newsgroups for Molecular Biology Lines: 12 Sender: daemon@net.bio.net Distribution: world Message-ID: NNTP-Posting-Host: net.bio.net It was suggested by Kevin that PCR is routinely used in the EC (EU) for testing for Psol (brown rot) and Cms (ring rot) in potato. Although I am aware that PCR methodologies exist for both these bacterial pathogens, I do not believe that they have been implemented for routine use. They have only been used experimentally to confirm diagnoses based on serological tests, as far as I know. Perhaps we could hear from the labs that are actually using PCR for these pathogens. Thanks, Solke From owner-diagnostics@net.bio.net Mon Jun 03 23:00:00 1996 Path: biosci!daresbury!nntp-trd.UNINETT.no!Norway.EU.net!nntp.uio.no!news.cais.net!newsfeed.internetmci.com!in2.uu.net!sleepy.inch.com!usenet From: Leonard Kalvert Newsgroups: bionet.diagnostics Subject: Re: Position Available - Scientist Date: 4 Jun 1996 15:35:36 GMT Organization: Kalvert Personnel Lines: 3 Message-ID: <4p1l48$lvl@sleepy.inch.com> References: <4p1kon$lvl@sleepy.inch.com> NNTP-Posting-Host: port308.dialup.inch.com Mime-Version: 1.0 Content-Type: text/plain; charset=us-ascii Content-Transfer-Encoding: 7bit X-Mailer: Mozilla 1.22 (Windows; I; 16bit) The Position is with a Midwestern Diagnostics company. Salary $42,000-$48,000 From owner-diagnostics@net.bio.net Mon Jun 03 23:00:00 1996 Path: biosci!bcm.tmc.edu!news.msfc.nasa.gov!elroy.jpl.nasa.gov!swrinde!newsfeed.internetmci.com!in2.uu.net!sleepy.inch.com!usenet From: Leonard Kalvert Newsgroups: bionet.diagnostics Subject: Position Available - Scientist Date: 4 Jun 1996 15:29:27 GMT Organization: Kalvert Personnel Lines: 24 Message-ID: <4p1kon$lvl@sleepy.inch.com> NNTP-Posting-Host: port308.dialup.inch.com Mime-Version: 1.0 Content-Type: text/plain; charset=us-ascii Content-Transfer-Encoding: 7bit X-Mailer: Mozilla 1.22 (Windows; I; 16bit) Scientist - Systems Engineering Department: Development and execution of sophisiticated experimental protocols, formal report development, select and implement appropriate analytical techniques, participate in work teams. Skills/Knowledge/Abilities: Familiar with the characterization and evaluation of sophisticated instrument systems in the diagnostics industry. Problem solving, critical thinking. Data organization, analysis, and presentation. Familiar with the use of the following types of software: spreadsheet, word processor, statistical analysis (SAS, Stat Graphics, MiniTab, Statistica), database. Solid working knowledge and experience in the application of statistical techniques (t-tests, ANOVA, experimental design. B.S. or M.S. in Biology or Medical Technology or Biomedical Engineering. Leonard Kalvert President Kalvert Personnel 866 United Nations Plaza, Suite 439 New York, NY 10017 (212)752-2626 (Tel) (212)752-2650 (Fax) kal@inch.com (e-mail) From owner-diagnostics@net.bio.net Wed Jun 05 23:00:00 1996 Path: biosci!rutgers!uwm.edu!lll-winken.llnl.gov!enews.sgi.com!su-news-feed4.bbnplanet.com!news1.slip.net!news From: seapilot@slip.net (seapilot) Newsgroups: bionet.diagnostics Subject: Used Freeze Dryer for diagnostics available Date: Wed, 05 Jun 1996 23:55:25 GMT Organization: Slip.Net Lines: 14 Message-ID: <4p56vj$6st@news1.slip.net> NNTP-Posting-Host: sf-asc-30-179.dialup.slip.net X-Newsreader: Forte Free Agent v0.55 8 square foot steam sterilizable lyophilizer with hydraulic internal stoppering. Chamber, door and shelves constructed of 304 stainless steel. Four usable shelves 12' W X 24" D with 4 1/2: clearance between shelves. Shelf temp -50 to +70 degrees C. Internal condenser, temp: -65 degrees C. Dryer dimensions 34" left to right X 60" deep X 72" high. Instrument panel dimensions 24" W X 24" D X 42" H. Excellent condition I have many other freeze dryers as well as autoclaves, fermenters and other quality items of pre owned equipment. Contact me on the www at http://www.firstenberg.com or email to Tom@firstenberg.com if you are looking for equipment or have items to sell. Tom Manuel From owner-diagnostics@net.bio.net Wed Jun 05 23:00:00 1996 Path: biosci!sasa.gov.uk!odonnell From: odonnell@sasa.gov.uk ("Kevin O'Donnell") Newsgroups: bionet.diagnostics Subject: (Fwd) Re: Commercial PP Molecular Diagnostics Date: 6 Jun 1996 01:40:01 -0700 Organization: Scottish Agricultural Science Agency Lines: 33 Sender: daemon@net.bio.net Distribution: world Message-ID: <9606060934.aa13144@jura.sasa.gov.uk> Reply-To: odonnell@sasa.gov.uk NNTP-Posting-Host: net.bio.net On 4 Jun 96 at 9:18, Solke Deboer wrote: > It was suggested by Kevin that PCR is routinely > used in the EC (EU) for testing for Psol (brown > rot) and Cms (ring rot) in potato. Although I am > aware that PCR methodologies exist for both these > bacterial pathogens, I do not believe that they have > been implemented for routine use. They have only > been used experimentally to confirm diagnoses > based on serological tests, as far as I know. > Perhaps we could hear from the labs that are > actually using PCR for these pathogens. > Thanks, Solke The two are not mutually incompatible - it depends on what is meant by 'routine' Solke:-) In the case of my own bacteriology laboratory, the PCR test for Brown Rot is used on all samples deemed to be high risk. Of course as well as being routine, this is also experimental because it does not yet have the status of a statutory test required by the EC. That may change. The point is though, that these assays are now being used to generate results of practical use rather than just to provide material for publications. I too would be interested in hearing from other laboratories. Kevin Dr Kevin O'Donnell "I'm happy, I'm happy Diagnostics and Molecular Biology and I'll punch the man that says I'm not" SASA - Ivor Cutler Edinburgh From owner-diagnostics@net.bio.net Fri Jun 07 23:00:00 1996 Path: biosci!data-transport.com!scott_jokerst From: scott_jokerst@data-transport.com (R. Scott Jokerst) Newsgroups: bionet.diagnostics Subject: Breast cancer info, and BRCA genes Date: 8 Jun 1996 16:21:13 -0700 Organization: BIOSCI International Newsgroups for Molecular Biology Lines: 34 Sender: daemon@net.bio.net Distribution: world Message-ID: NNTP-Posting-Host: net.bio.net Another good starting resource for your quest for information would be Biological Data Transport's resource at: http://www.data-transport.com Once there, go to the TransportSelect service, which can search several web resources simultaneously. Enter your query term, in this case: breast cancer Make sure to turn the checks ON for the external resources which interest you. I turned them all on. When the results came back, I followed one of the links from OMIM (an excellent "encyclopedia" of gene resource information in man). There are several other relevant links that also come back which you may be interested in, discussing BRCA-1, -2, etc. These links will give you a great deal of starting info on breast cancer. Hope this may be helpful, Scott *********** > > Does anyone have any thoughts or info on the BRCA breast cancer genes? I am > doing a paper on them. > > Any help would be appreciated. > R. Scott Jokerst (510-648-8229) scott_jokerst@data-transport.com Biological Data Transport http://www.data-transport.com Bringing FOCUS to life sciences informatics, product, & services resources From owner-diagnostics@net.bio.net Sun Jun 09 23:00:00 1996 Path: biosci!COMPUSERVE.COM!106123.3400 From: 106123.3400@COMPUSERVE.COM Newsgroups: bionet.diagnostics Subject: MOLECULAR PLANT PATHOLOGY ON-LINE submission Date: 10 Jun 1996 05:30:43 -0700 Organization: BIOSCI International Newsgroups for Molecular Biology Lines: 4 Sender: daemon@net.bio.net Distribution: world Message-ID: <199606101227.IAA08302@dub-mail-svc-1.compuserve.com> NNTP-Posting-Host: net.bio.net Molecular Plant Pathology On-Line An exciting new way to publish research in molecular plant pathology and nematology developed by the British Society for Plant Pathology. Please note a change of address for submissions: Dr Debra Whitehead - <106123.3400@compuserve.com From owner-diagnostics@net.bio.net Tue Jun 11 23:00:00 1996 Path: biosci!rutgers!uwm.edu!vixen.cso.uiuc.edu!newsfeed.internetmci.com!tank.news.pipex.net!pipex!dispatch.news.demon.net!demon!mail2news.demon.co.uk!interlink-bbs.com From: alas@babylon Newsgroups: bionet.diagnostics Subject: ALAS BABYLON Date: Wed, 12 Jun 1996 02:17:24 GMT Lines: 7 Message-ID: <9606111242.D4831JE@interlink-bbs.com> X-NNTP-Posting-Host: interlink-bbs.com X-Broken-Date: 06-11-1996 X-Mailer: UUPlus Mail 1.53 X-Mail2News-Path: sparky.midwest.net!interlink-bbs.com ALAS BABYLON From owner-diagnostics@net.bio.net Tue Jun 11 23:00:00 1996 Path: biosci!bcm.tmc.edu!news.msfc.nasa.gov!elroy.jpl.nasa.gov!usc!newshub.cts.com!usenet From: b3748@cts.com (Bryan Kiehl) Newsgroups: bionet.diagnostics Subject: Re: elisa Date: Wed, 12 Jun 1996 15:49:26 GMT Organization: CTS Network Services Lines: 21 Message-ID: <4pmouf$skv@news2.cts.com> References: <31BE2543.3747@uninet.com.br> NNTP-Posting-Host: kiehl.cts.com Douglas, In general you can divide these into serology or antigen detection. You can usually develop one protocol for serology. The key for serology is usually antigen quality. However, direct antigen tests rely on the quality of the antibody, but also usually rely on more factors. It is unlikely that you can have one format. Douglas Andreas Valverde wrote: >Please, i am looking for protocols for elisa in infectious diseases like >Toxo IgM, HIV, T.cruzi,HBsAg,HBcAg. >thanks. >Douglas Bryan Kiehl b3748@cts.com San Diego, CA From owner-diagnostics@net.bio.net Tue Jun 11 23:00:00 1996 Newsgroups: bionet.diagnostics Path: biosci!rutgers!uwm.edu!vixen.cso.uiuc.edu!howland.reston.ans.net!tank.news.pipex.net!pipex!dish.news.pipex.net!pipex!sasa.gov.uk!news From: Kevin O'Donnell Subject: Re: rec.pets.cats DEFEATS alt.bigfoot and alt.syntax.tactical Content-Type: text/plain; charset=us-ascii Organization: Scottish Agricultural Scinece Agency Date: Wed, 12 Jun 1996 10:54:09 GMT Message-ID: To: biosci-help@net.bio.net X-Mailer: Mozilla 1.22 (Windows; I; 16bit) Mime-Version: 1.0 X-Nntp-Posting-Host: comp128.sasa.gov.uk Content-Transfer-Encoding: 7bit References: <123456789@987654321> Sender: news@sasa.gov.uk (Usenet) Lines: 14 It appears we are the victim of a 'troll' which has been posted to a number of newsgroups including our own. I am copying this post to the good folks at biosci who are better able to deal with it than us. In the meantime, let's not make matters worse by responding in kind - or if you do feel the need to vent some spleen, do it by private email to the individual concerned and copy it to postmaster@their.site. Don't post responses here - it'll only encourage them. Kevin Kevin O'Donnell SASA Edinburgh From owner-diagnostics@net.bio.net Tue Jun 11 23:00:00 1996 Path: biosci!bcm.tmc.edu!news.msfc.nasa.gov!elroy.jpl.nasa.gov!swrinde!howland.reston.ans.net!vixen.cso.uiuc.edu!news.uoregon.edu!news.unisys.com.br!news From: Douglas Andreas Valverde Newsgroups: bionet.diagnostics Subject: elisa Date: Wed, 12 Jun 1996 00:02:43 -0200 Organization: Unisys Brasil Ltda. (Sao Paulo - Brazil) Lines: 6 Message-ID: <31BE2543.3747@uninet.com.br> NNTP-Posting-Host: saonb03p26.unisys.com.br Mime-Version: 1.0 Content-Type: text/plain; charset=us-ascii Content-Transfer-Encoding: 7bit X-Mailer: Mozilla 2.01Gold (Win95; I) Please, i am looking for protocols for elisa in infectious diseases like Toxo IgM, HIV, T.cruzi,HBsAg,HBcAg. thanks. Douglas From owner-diagnostics@net.bio.net Tue Jun 11 23:00:00 1996 Path: biosci!bcm.tmc.edu!news.msfc.nasa.gov!elroy.jpl.nasa.gov!swrinde!tank.news.pipex.net!pipex!dispatch.news.demon.net!demon!user From: filter@firthcom.demon.co.uk (Steve Firth) Newsgroups: bionet.diagnostics Subject: Re: elisa Date: Wed, 12 Jun 1996 22:45:17 +0100 Organization: Firth Consulting Lines: 18 Message-ID: References: <31BE2543.3747@uninet.com.br> <4pmouf$skv@news2.cts.com> NNTP-Posting-Host: firthcom.demon.co.uk X-NNTP-Posting-Host: firthcom.demon.co.uk Mime-Version: 1.0 Content-Type: text/plain; charset=iso-8859-1 Content-Transfer-Encoding: 8bit In article <4pmouf$skv@news2.cts.com>, b3748@cts.com (Bryan Kiehl) wrote: >In general you can divide these into serology or antigen detection. >You can usually develop one protocol for serology. The key for >serology is usually antigen quality. having once spent five years of my life devloping good tests for some of these analytes, I'll "me too" Bryan's statement. To make a good test will take a lot of time, and you must perform some painstaking titrations to get good performance from your raw materials. I'd recommend going for a commercial assay unless you have a lot of experience of immunoassay design and standardisation. Somehow though I have the feeling that if you had the experience required, you probably wouldn't be asking for help. From owner-diagnostics@net.bio.net Tue Jun 11 23:00:00 1996 Path: biosci!daresbury!nntp-trd.UNINETT.no!Norway.EU.net!nntp.uio.no!news.cais.net!newsfeed.internetmci.com!news.mdn.com!news From: Jeff klaybor Newsgroups: bionet.diagnostics Subject: Shareware Date: Wed, 12 Jun 1996 17:15:10 -0500 Organization: Metropolitan Data Networks, 317.449.0539 Lines: 15 Message-ID: <31BF416E.68DB@mtco.com> NNTP-Posting-Host: peo46.mtco.com Mime-Version: 1.0 Content-Type: text/plain; charset=us-ascii Content-Transfer-Encoding: 7bit X-Mailer: Mozilla 3.0b4 (Win95; I) check out http://www.mtco.com/~invfib/jtcalc.html for a cardiopulmonary shareware program -- _..--''``\--....__ _..,_ ____ _.-'` .-/"; ` ```<._ ``-+'~=. ____ / .-' _..--.'_ \ `(^) ) / / ((.-' (< _ ;.__ ; `~ / / `-._,_)'`` ```--..._____..-' / /Just Loafing on the 'NET, thought I'd mail you / ````````````````````````````````````````````````` ____ _ _ _ _ ____ ____ ____ (_ _)( \( )( \/ )( ___)(_ _)( _ \ _)(_ ) ( \ / )__) _)(_ ) _ < (____)(_)\_) \/ (__) (____)(____/ From owner-diagnostics@net.bio.net Wed Jun 12 23:00:00 1996 Path: biosci!daresbury!not-for-mail From: Eduardo Perez Campos Newsgroups: bionet.diagnostics Subject: Info- haematology news group Date: 13 Jun 1996 15:28:35 +0100 Lines: 22 Sender: lpddist@mserv1.dl.ac.uk Distribution: bionet Message-ID: <4pp8ij$s34@mserv1.dl.ac.uk> MIME-Version: 1.0 X-Chameleon-Return-To: laborato@antequera.antequera.com Original-To: IGA-L@NERVM.NERDC.UFL.EDU, diagnost@dl.ac.uk, diagnost@net.bio.net Dear netters: I am looking for information about coagulation/ thrombosis or haematology news group. Any information would be appreciated. Eduardo Eduardo Perez-Campos E-mail: laborato@antequera.antequera.com ------------------------------------- Eduardo Perez-Campos Laboratory of Clinical Pathology Zaragoza 213, Oaxaca. Oax. CP 68000, Mexico. Phone and Fax: (951)6-11-40 E-mail: laborato@antequera.antequera.com 06/12/96 21:06:31 ------------------------------------- From owner-diagnostics@net.bio.net Wed Jun 12 23:00:00 1996 Path: biosci!UNIXG.UBC.CA!idb From: idb@UNIXG.UBC.CA (Peter Duck) Newsgroups: bionet.diagnostics Subject: unsubscribe Date: 13 Jun 1996 16:02:58 -0700 Organization: BIOSCI International Newsgroups for Molecular Biology Lines: 1 Sender: daemon@net.bio.net Distribution: world Message-ID: NNTP-Posting-Host: net.bio.net From owner-diagnostics@net.bio.net Wed Jun 12 23:00:00 1996 Path: biosci!bcm.tmc.edu!news.msfc.nasa.gov!elroy.jpl.nasa.gov!swrinde!newsfeed.internetmci.com!csn!nntp-xfer-1.csn.net!magnus.acs.ohio-state.edu!usenet.ins.cwru.edu!slider.bme.ri.ccf.org!news From: Urs Hafeli Newsgroups: bionet.diagnostics Subject: Meeting Announcement again Date: Thu, 13 Jun 1996 14:16:06 -0400 Organization: The Cleveland Clinic Foundation Lines: 12 Message-ID: <31C05AE6.58B7@radonc.ccf.org> NNTP-Posting-Host: radtpc2.ccf.org Mime-Version: 1.0 Content-Type: text/plain; charset=iso-8859-1 Content-Transfer-Encoding: 8bit X-Mailer: Mozilla 3.0b4Gold (Win95; I) Sorry, it didn’t take my URL right: Let’s try again: ********** UPDATES AND INFORMATION ON THE INTERNET: ********** ------------------------------------------------------------ First International Conference on the BASIC AND CLINICAL APPLICATIONS OF MAGNETIC CARRIERS September 5-7, 1996 Rostock, Germany ------------------------------------------------------------ http://www.ccf.org/cc/radonc/conferences/mag_carriers.html From owner-diagnostics@net.bio.net Wed Jun 12 23:00:00 1996 Path: biosci!daresbury!nntp-trd.UNINETT.no!Norway.EU.net!nntp.uio.no!news.cais.net!newsfeed.internetmci.com!howland.reston.ans.net!usenet.ins.cwru.edu!slider.bme.ri.ccf.org!news From: Urs Hafeli Newsgroups: bionet.diagnostics Subject: MEETING ANNOUNCEMENT: Magnetic Carriers Date: Thu, 13 Jun 1996 14:06:18 -0400 Organization: The Cleveland Clinic Foundation Lines: 87 Message-ID: <31C0589A.7F9C@radonc.ccf.org> NNTP-Posting-Host: radtpc2.ccf.org Mime-Version: 1.0 Content-Type: text/plain; charset=iso-8859-1 Content-Transfer-Encoding: 8bit X-Mailer: Mozilla 3.0b4Gold (Win95; I) ***** FINAL CALL FOR PAPERS ***** ***** DEADLINE FOR ABSTRACTS: AUGUST 9, 1996 ***** ------------------------------------------------------------ First International Conference on the BASIC AND CLINICAL APPLICATIONS OF MAGNETIC CARRIERS September 5-7, 1996 Rostock, Germany ------------------------------------------------------------ ********** AIM: *********** This conference is the first meeting devoted exclusively to the use and application of magnetic microspheres in the basic and clinical sciences. The aim of this meeting is to bring together scientists from research, universities and industries involved in the magnetic and clinical sciences, to facilitate the exchange of knowledge and information in this cross-disciplinary field and to promote innovative industrial applications. ********** SCIENTIFIC PROGRAM: ********** 1. Basic Concepts: Physics and Chemistry of Magnetic Particle Formation, Structure and Magnetism 2. Preparation and Characterization of Magnetic Particles: Ferrofluids, Polymer and Colloid Chemistry, Surface Modifications, Particle Separation, Structure Analysis, Size Distribution, Laser Scanning Microscopy, Photon Correlation Spectroscopy, Electro- and Magnetophoresis, Zero Gravity Magnetophoresis (Space Shuttle Experiments) 3. Applications in Molecular and Cell Biology: DNA/RNA Purification, Receptor Identification, Cell Culture, Immunoassays, In vitro Diagnostics, Micromechanic Cell Stimulation 4. Analytical, Preparative and Clinical Cell Separation: Specific Cell Labeling and Separation, Cell Counting, Automatization, Microchips, Lymphoid Cell Extraction, Bone Marrow Purging, Pancreatic Islets, Bacteria Isolation, Receptor Density 5. Clinical Applications: Magnetic Resonance Contrast Enhancement, Nuclear Medicine / Cancer Treatment, Drug Delivery / Local Targeting, Hyperthermia, Pneumology, Artificial Organs, Detoxification, AIDS Therapy Concept ********** LIST OF SPEAKERS: ********** R. Arshady (London), H. Aurich (Halle), S. Baatout (Belgium), J. Bacri (Paris), G. Blankenstein (Danmark), A.J. Dukhin (New York), J. Feijen (Enschede), V. Filippov (Moscow), C. Grüttner (Rostock), J.M. Gallo (Philadelphia), L. Goncharoc (Moscow), I. Granicka (Warsaw), G. Grümmer (Rostock), U. Häfeli (Cleveland), A. Halbreich (Paris), R. Hartig (Ladenberg), M. Hausmann (Heidelberg), J. Humm (New York), A. Jordan (Berlin), M. Katushev (Moscow), L.H. Komissarova (Moscow), L. Korsnes (Oslo), St. Kraeft (Boston), M. Kresse (Berlin), A. Kusnetzov (Moscow), O. Kusnetzov (U.S.A.), K.H. Lerche (Berlin), P.A. Liberti (U.S.A.), S. Machmutov (Moscow), A.G. Malenkov (Moscow), S. Margel (Israel), T. Matsunaga (Japan), M. Meza (U.S.A.), St. Miltenyi (Gladbach), W. Möller (Munich), R. Müller (Berlin), W. Müller-Ruchholtz (Kiel), D. Müller-Schulte (Aachen), Thien N'Guyen (Switzerland), H. Notbohm (Lübeck), R. Paulke (Teltow), J. Plavins (Latvia), M. Pluzian (Armenia), V.I. Popova (Moscow), H. Putzar (Rostock), A. Rian (Oslo), J. Roger (Paris), W. Rutz (Rostock), E. Ruuge (Moscow), D. Sabolovic (Paris), C. Schümichen (Rostock), W. Schütt (Rostock), I. Siddiqui (U.S.A.), K. Sievers (Rostock), K. Smith (Boston), P. Stenstad (Oslo), V. Tchikov (Moscow), J. Teller (Rostock), K. Thode (Berlin), L. Tiefenauer (Switzerland), J. Ugelstad (Trondheim), I. van der Klei (The Netherlands), M. Veenhuis (The Netherlands), M. Vladimirsky (Moscow), Ch. Weber (Krems), G. Weber (Munich), F. Winnik (Canada), S. Winoto-Morbach (Kiel), M. Zborowski (Cleveland) ******* REGISTRATION, ORGANIZATION AND INFORMATION: ******* Urs Häfeli The Cleveland Clinic Foundation Radiation Oncology Dept. 9500 Euclid Ave. T28 Tel: 1-216 444 2174 Cleveland, OH 44195 Fax: 1-216 445 4480 U.S.A. e-mail: hafeli@radonc.ccf.org or Wolfgang Schütt University of Rostock Division Nuclear Medicine Gertrudenplatz Tel: 49-381 494 9012 18055 Rostock Fax: 49-381 494 9102 Germany ********** UPDATES AND INFORMATION ON THE INTERNET: ******** http://www.ccf.org/cc/radonc/conferences/mag_carriers From owner-diagnostics@net.bio.net Thu Jun 13 23:00:00 1996 Path: biosci!ARNIE.CFI.UNSW.EDU.AU!p.french From: p.french@ARNIE.CFI.UNSW.EDU.AU (Peter French) Newsgroups: bionet.diagnostics Subject: (none) Date: 13 Jun 1996 18:46:34 -0700 Organization: BIOSCI International Newsgroups for Molecular Biology Lines: 10 Sender: daemon@net.bio.net Distribution: world Message-ID: <199606140105.MAA13292@arnie.cfi.unsw.EDU.AU> NNTP-Posting-Host: net.bio.net unsubscribe Peter French, Centre for Immunology, St Vincent's Hospital, Sydney. President, ANZSCBI phone 61-2-361-2388 fax 61-2-361-2391 mobile 018-412-961 From owner-diagnostics@net.bio.net Thu Jun 13 23:00:00 1996 Path: biosci!ARNIE.CFI.UNSW.EDU.AU!p.french From: p.french@ARNIE.CFI.UNSW.EDU.AU (Peter French) Newsgroups: bionet.diagnostics Subject: Re: rubbish postings Date: 13 Jun 1996 18:45:18 -0700 Organization: BIOSCI International Newsgroups for Molecular Biology Lines: 7 Sender: daemon@net.bio.net Distribution: world Message-ID: <199606140104.MAA13241@arnie.cfi.unsw.EDU.AU> NNTP-Posting-Host: net.bio.net If this rubbish string reflects the quality of the intelligence of the members of this newsgroup, I can gain greater insights from reading the local newspaper. Thank you all, and goodbye! I encourage all like minded people to do the sam, and unsubscribe. From owner-diagnostics@net.bio.net Thu Jun 13 23:00:00 1996 Path: biosci!sasa.gov.uk!odonnell From: odonnell@sasa.gov.uk ("Kevin O'Donnell") Newsgroups: bionet.diagnostics Subject: Moderation for bionet.diagnostics Date: 14 Jun 1996 02:08:48 -0700 Organization: Scottish Agricultural Science Agency Lines: 36 Sender: daemon@net.bio.net Distribution: world Message-ID: <9606141003.aa05328@jura.sasa.gov.uk> Reply-To: odonnell@sasa.gov.uk NNTP-Posting-Host: net.bio.net As you will have noticed we are currently caught up in a flame war raging across several newsgroups. I fully appreciate that this is not why any of us read bionet.diagnostics. I don't however think that unsubscribing, and encouraging others to do so, is the most positive response. Nor are these posts a reflection of anyone subscribed to bionet.diagnostics - they all originate from other newsgroups. Sadly, I can see only one way to stop this sort of thing happening now and in the future - we will have to turn bionet.diagnostics into a moderated newsgroup. This can be done quite quickly I understand. What it would involve would be posts being approved by moderators before they appear here. This would cut out the dross but also cause a delay in the time it took for your posts to appear. As we are losing subscribers at a rate of knots, I propose to hold a straw poll on moderation. Send me (not the list) an email response *today* saying either YES TO MODERATION or NO TO MODERATION. If there's a clear feeling in favour of moderation , I'll ask Biosci to set us up as a moderated group. For the moment I envisage that the current "discussion-leaders" (myself and Robert Burns) would act as moderators. People are, of course, free to discuss the pros and cons of moderation on the group. It's sad that it's come to this but it appears that the number of idiots is growing along with the rest of the net. Kevin Dr Kevin O'Donnell "I'm happy, I'm happy Diagnostics and Molecular Biology and I'll punch the man that says I'm not" SASA - Ivor Cutler Edinburgh From owner-diagnostics@net.bio.net Thu Jun 13 23:00:00 1996 Path: biosci!daresbury!nntp-trd.UNINETT.no!nntp.uio.no!news.cais.net!newsfeed.internetmci.com!swrinde!news.uh.edu!usenet From: hreynolds@uh.edu Newsgroups: bionet.diagnostics Subject: Immundiagnostic Distributor Wanted Date: 14 Jun 1996 03:04:45 GMT Organization: University of Houston Lines: 16 Message-ID: <4pqksd$sn9@masala.cc.uh.edu> NNTP-Posting-Host: sip-14317.public-dialups.uh.edu Mime-Version: 1.0 Content-Type: text/plain; charset=us-ascii Content-Transfer-Encoding: 7bit X-Mailer: Mozilla 1.22 (Windows; I; 16bit) Diagnostic Systems Laboratories would like to discuss potential distributorship relations with companies throughout the globe. Our products are in the following categories: Growth Factors, Fertility and Reproductive Function, Bone Metabolism, Pituitary-Adrenal Axis, Thyroid Function, Disease Markers, and Diabetes Management. Only serious and honest inquiries please. Preston Reynolds Diagnostic Systems Laboratories 445 Medical Center Blvd. Webster, TX 77598 phone: 713.332.9678 fax: 713.338.1895 e-mail: mktg@dslabs.com From owner-diagnostics@net.bio.net Thu Jun 13 23:00:00 1996 Path: biosci!rutgers!uwm.edu!vixen.cso.uiuc.edu!newsfeed.internetmci.com!news.msfc.nasa.gov!elroy.jpl.nasa.gov!swrinde!news.uh.edu!usenet From: hreynolds@uh.edu Newsgroups: bionet.diagnostics Subject: Immunodiagnostic Distributor Wanted Date: 14 Jun 1996 03:00:03 GMT Organization: University of Houston Lines: 17 Message-ID: <4pqkjj$shd@masala.cc.uh.edu> NNTP-Posting-Host: sip-14317.public-dialups.uh.edu Mime-Version: 1.0 Content-Type: text/plain; charset=us-ascii Content-Transfer-Encoding: 7bit X-Mailer: Mozilla 1.22 (Windows; I; 16bit) Diagnostic Systems Laboratories would like to discuss potential distributorship relations with companies throughout the globe. Our products are in the following categories: Growth Factors, Fertility and Reproductive Function, Bone Metabolism, Pituitary-Adrenal Axis, Thyroid Function, Disease Markers, and Diabetes Management. Only serious and honest inquiries please. Preston Reynolds Diagnostic Systems Laboratories 445 Medical Center Blvd. Webster, TX 77598 phone: 713.332.9678 fax: 713.338.1895 e-mail: mktg@dslabs.com From owner-diagnostics@net.bio.net Thu Jun 13 23:00:00 1996 Path: biosci!daresbury!nntp-trd.UNINETT.no!Norway.EU.net!nntp.uio.no!news.cais.net!newsfeed.internetmci.com!swrinde!news.uh.edu!usenet From: hreynolds@uh.edu Newsgroups: bionet.diagnostics Subject: Osteoporosis-Bone Resorption Marker Date: 14 Jun 1996 18:15:27 GMT Organization: University of Houston Lines: 75 Message-ID: <4psa7v$6hg@masala.cc.uh.edu> NNTP-Posting-Host: sip-14184.public-dialups.uh.edu Mime-Version: 1.0 Content-Type: text/plain; charset=iso-8859-1 Content-Transfer-Encoding: 8bit X-Mailer: Mozilla 1.22 (Windows; I; 16bit) The ACTIVE CrossLaps ELISA kit is designed for the specific quantitative measurement of C-telopeptide degradation products of type I collagen (CrossLaps) in urine, and is intended for in vitro diagnostic use as an indicator of human bone resorption. Type I collagen comprises 90% of the organic matrix of bone and is synthesized primarily in bone. During bone remodeling, type I collagen is degraded and the small peptide fragments are excreted in the urine. The high specificity of the ACTIVE CrossLaps ELISA for this degradation product of type I collagen makes the quantitative measurement of CrossLaps an excellent marker of bone resorption. The ACTIVE CrossLaps ELISA is a 96-well kit featuring the convenience of a microtitre-plate format, a total assay incubation time of 2 hours and 15 minutes, and sensitivity to 50 µg/L. The standard range of this assay is 100 - 5000 µg/L of the CrossLaps antigen, and a single urine control is included with the kit. Due to the biological variability observed with urine specimens collected at various time points, second morning void urine sampling is preferred. Additionally, preservatives commonly used in urine specimens do not affect the performance of the CrossLaps ELISA. This is an important consideration for assays of urine specimens since urine is typically collected in the presence of a preservative(s). The assay is based on the competitive binding of the anti-CrossLaps antibodies to either soluble CrossLaps antigen or to CrossLaps antigen-coated microtitration wells. Standards, controls and unknowns are added to the appropriate wells, then the anti-CrossLaps antibodies are added, and the wells are incubated for 1 hour. The wells are washed and peroxidase conjugated anti-rabbit immunoglobulin is added. The wells are then incubated again for 1 hour. After a second washing step, the wells are incubated for 15 minutes with a chromogenic substrate (TMB), and the enzymatic reaction is stopped by the addition of phosphoric acid. The optical density of each of the wells is read at 450 nm. The highly specific and sensitive CrossLaps ELISA is an effective tool for monitoring patient response to anti-resorptive therapies, and assessing bone resorption activity in patients with metabolic bone disease. Bone remodeling is a dynamic process whereby bone is degraded and reformed on a continuous basis. Healthy bone is a balance of these two processes. Osteoporosis is a disorder characterized by an imbalance in bone remodeling in which the rate of bone resorption exceeds that of bone formation. According to the National Osteoporosis Foundation (NOF), osteoporosis affects more than 25 million people in the United States, 80 percent of whom are women. Forty percent of all women have at least one spinal fracture by the time they reach 80 years of age. One third of all men will be affected by osteoporosis by age 75. Overall costs associated with diagnosis and treatment of osteoporosis exceed $10 billion per year and will likely increase as the aging population continues to grow. In addition to the use of hormone replacement therapies for postmenopausal osteoporosis patients, various pharmaceutical agents intended to inhibit bone resorption are currently in development or under investigation. Sensitive and responsive assays of exclusive biochemical markers of bone resorption and bone formation are the rational, cost-effective approach to monitoring patient response to such anti-resorptive therapies. In addition to the ACTIVE CrossLaps ELISA kit, DSL offers a comprehensive panel of assays related to bone metabolism and calcium regulation. The DSL Bone and Mineral Metabolism product line also features assays for human osteocalcin, intact-PTH, human calcitonin, salmon calcitonin, and more. DSL (Diagnostic Systems Laboratories, Inc.) has received FDA 510(k) clearance to market the DSL-10-1700, ACTIVE CrossLaps ELISA kit. The DSL ACTIVE CrossLaps ELISA (catalogue number DSL-10-1700) is available in North America exclusively from DSL, Inc. For more information regarding this assay and other DSL products, contact the DSL Customer Service Center in Webster, TX, USA by phone 800.231.7970 or 713.332.9678, by fax 713.338.1895, or by e-mail mktg@dslabs.com Diagnostic Systems Laboratories 445 Medical Center Blvd. Webster, TX 77598 From owner-diagnostics@net.bio.net Thu Jun 13 23:00:00 1996 Path: biosci!rutgers!csn!nntp-xfer-1.csn.net!imci3!newsfeed.internetmci.com!swrinde!news.uh.edu!usenet From: hreynolds@uh.edu Newsgroups: bionet.diagnostics Subject: IGF-I, Non-Extraction Date: 14 Jun 1996 18:05:40 GMT Organization: University of Houston Lines: 70 Message-ID: <4ps9lk$6hg@masala.cc.uh.edu> NNTP-Posting-Host: sip-14184.public-dialups.uh.edu Mime-Version: 1.0 Content-Type: text/plain; charset=iso-8859-1 Content-Transfer-Encoding: 8bit X-Mailer: Mozilla 1.22 (Windows; I; 16bit) DSL (Diagnostic Systems Laboratories, Inc.) is pleased to introduce the NEW Non-Extraction IGF-I IRMA and ELISA kits for quantifying IGF-I in serum and plasma without the necessity of performing time-consuming and equipment-intensive extraction procedures. The Non-Extraction IGF-I assay is 510(k) cleared for marketing for in vitro diagnostic use as an aid in the diagnosis of growth-related disorders. IGF-I is a 7.6 kDa, 70 amino acid peptide that mediates the actions of growth hormone. It is secreted by the liver and several other tissues and is postulated to have mitogenic and metabolic actions at or near the sites of synthesis. IGF-I appears in the peripheral circulation primarily in a high molecular weight complex with IGF-binding protein-3 and acid-labile subunit (ALS). A smaller proportion of IGF-I may circulate in association with other IGF-binding proteins. Approximately 2-4% of the total IGF-I may circulate unbound. The IGF-I assays are useful in the diagnosis of growth-related disorders. Abnormally low IGF-I levels may be a diagnostic indicator of growth hormone deficiency. Conversely, elevated IGF-I levels may be indicative of growth hormone excess. Direct testing of growth hormone may be clinically unreliable due to its episodic release from the pituitary and relatively short half-life in the circulation, whereas IGF-I levels remain relatively stable throughout the day. Immunoassay of IGF-I may be complicated by the presence of the high affinity binding proteins in the sample. Historically, it has been necessary to separate the IGFs from the binding proteins prior to assaying for IGF-I. The traditional extraction procedures, including chromatography, multiple acidification and neutralization steps, and centrifugation to prepare the samples are no longer required when using the DSL Non-Extraction IGF-I assays. The specimens are simply diluted in the sample diluent provided and allowed to equilibrate at room temperature for 30 minutes. The DSL assay kits utilize a two-site antibody system with highly specific antibodies directed against the human insulin-like growth factor-I peptide. No cross-reactivity with IGF-II is exhibited, and no interference results from the addition of insulin, proinsulin, or growth hormone at concentrations of 1 µg/tube. The DSL ACTIVE Non-Extraction IGF-I IRMA is a 100 tube kit featuring the convenience of an antibody-coated tube format and a total assay incubation time of only 2 hours. The DSL ACTIVE Non-Extraction IGF-I ELISA is a 96-well microtitre plate assay featuring a total assay incubation time of 2.5 hours. Both assays are calibrated using the World Health Organization international reference preparation for IGF-I immunoassay (code 87/518). The assays feature an extended standard range of 8 - 1000 ng/mL. The absolute sensitivity of the IGF-I IRMA kit is 0.04 ng/mL, and the absolute sensitivity of the ELISA is 0.03 ng/mL. Both kits include two levels of controls. In addition to the ACTIVE Non-Extraction IGF-I IRMA and ELISA kits, DSL offers a full range of immunodiagnostic test kits and reagents for studies related to disorders of the growth hormone-IGF axis, an extensive line of assays for the studies of bone and mineral metabolism, a complete line of assays for fertility and reproductive function, androgen assessment, and more. For more information regarding the ACTIVE Non-Extraction IGF-I IRMA and ELISA kits (catalog numbers DSL-2800 and DSL-10-2800, respectively) as well as other DSL products and services, contact the DSL Customer Assistance Center in Webster, TX, USA by phone 800.231.7970 or 713.332.9678, by fax 713.338.1895, or by e-mail mktg@dslabs.com Diagnostic Systems Laboratories 445 Medical Center Blvd. Webster, TX 77598 From owner-diagnostics@net.bio.net Thu Jun 13 23:00:00 1996 Path: biosci!sasa.gov.uk!odonnell From: odonnell@sasa.gov.uk ("Kevin O'Donnell") Newsgroups: bionet.diagnostics Subject: Straw Poll Results Date: 14 Jun 1996 08:16:32 -0700 Organization: Scottish Agricultural Science Agency Lines: 13 Sender: daemon@net.bio.net Distribution: world Message-ID: <9606141610.aa13643@jura.sasa.gov.uk> Reply-To: odonnell@sasa.gov.uk NNTP-Posting-Host: net.bio.net The straw poll has already generated 20 votes for moderation and only 3 against. On that basis, and barring a sudden flood of anti-moderation votes, I have asked Biosci to make the group moderated. This should happen quite soon - we will keep you posted regarding developments. Kevin Dr Kevin O'Donnell "I'm happy, I'm happy Diagnostics and Molecular Biology and I'll punch the man that says I'm not" SASA - Ivor Cutler Edinburgh From owner-diagnostics@net.bio.net Fri Jun 14 23:00:00 1996 Path: biosci!rutgers!uwm.edu!news.cse.psu.edu!news.math.psu.edu!news.cac.psu.edu!howland.reston.ans.net!tank.news.pipex.net!pipex!netcom.net.uk!dispatch.news.demon.net!demon!user From: filter@firthcom.demon.co.uk (Steve Firth) Newsgroups: bionet.diagnostics Subject: Re: Moderation for bionet.diagnostics Date: Sat, 15 Jun 1996 12:41:03 +0100 Organization: Firth Consulting Lines: 15 Message-ID: References: <9606141003.aa05328@jura.sasa.gov.uk> NNTP-Posting-Host: firthcom.demon.co.uk X-NNTP-Posting-Host: firthcom.demon.co.uk Mime-Version: 1.0 Content-Type: text/plain; charset=iso-8859-1 Content-Transfer-Encoding: 8bit In article <9606141003.aa05328@jura.sasa.gov.uk>, odonnell@sasa.gov.uk ("Kevin O'Donnell") wrote: >As you will have noticed we are currently caught up in a flame war >raging across several newsgroups. I fully appreciate that this is not >why any of us read bionet.diagnostics. This may sound silly, but no such flame war has penetrated to my server. Is this confined to the mailing list? For some reason I was unsubscribed from the mailing list without my requesting it, and I've had the feeling that the newsgroup is *very* quiet. Can someone enlighten me about what's going on? From owner-diagnostics@net.bio.net Sat Jun 15 23:00:00 1996 Path: biosci!rutgers!uwm.edu!cs.utexas.edu!swrinde!elroy.jpl.nasa.gov!news.msfc.nasa.gov!newsfeed.internetmci.com!in2.uu.net!news.ios.com!usenet From: KrisPrasad Newsgroups: bionet.diagnostics Subject: Re: Moderation for bionet.diagnostics Date: 16 Jun 1996 17:30:32 GMT Organization: Internet Online Services Lines: 2 Message-ID: <4q1gbo$ius@news.ios.com> References: <9606141003.aa05328@jura.sasa.gov.uk> NNTP-Posting-Host: ppp-68.ts-9.hck.idt.net Mime-Version: 1.0 Content-Type: text/plain; charset=us-ascii Content-Transfer-Encoding: 7bit X-Mailer: Mozilla 1.2 (Windows; U; 16bit) To: odonnell@sasa.gov.uk yes to moderation. this should certainly improve the quality of postings. From owner-diagnostics@net.bio.net Sun Jun 16 23:00:00 1996 Path: biosci!CRHA-Health.Ab.Ca!Paddy.Gibb From: Paddy.Gibb@CRHA-Health.Ab.Ca Newsgroups: bionet.diagnostics Subject: Re: early diagnosis = money? Date: 17 Jun 1996 09:00:22 -0700 Organization: BIOSCI International Newsgroups for Molecular Biology Lines: 26 Sender: daemon@net.bio.net Distribution: world Message-ID: <01I60EW3OVOM000V37@snuffy.fhhosp.ab.ca> Reply-To: Paddy.Gibb@CRHA-Health.Ab.Ca NNTP-Posting-Host: net.bio.net >From: millerj@knoxy.agvic.gov.au (James Miller) >Subject: early diagnosis = money? > > >I'm sure most diagnosticians/pathologists believe/know that early >diagnosis of a pest / pathogen / disease is advantageous for a grower >as he/she can take control measures and minimise losses. > >I am interested in finding SPECIFIC EXAMPLES This is a critical question for anyone organising labs or selling test kits, but there is very little good data. I would also like to here of examples. Part of the problem is the difficulty in doing such studies, and part of it is laboratory folks who are more interested in other aspects of their work. One study supporting the idea is Doern et al, J Clin Micro 1994:32;1757-1762. They compared a rapid method and a traditional method for susceptibility testing of bacteria and found savings in hospital costs as well as lower mortality rates. Seems almost too good to be true. Paddy Gibb From owner-diagnostics@net.bio.net Sun Jun 16 23:00:00 1996 Path: biosci!bcm.tmc.edu!cs.utexas.edu!howland.reston.ans.net!nntp.coast.net!swidir.switch.ch!swsbe6.switch.ch!fwsrva.bfi.admin.ch!usenet From: scicluna@ivi.admin.ch (Luke Scicluna) Newsgroups: bionet.diagnostics Subject: calculations Date: 17 Jun 1996 13:46:05 GMT Organization: BFI, Bern (Switzerland) Lines: 40 Message-ID: <4q3nit$v04@fwsrva.bfi.admin.ch> Reply-To: scicluna@ivi.admin.ch (Luke Scicluna) NNTP-Posting-Host: io.ivi.admin.ch Could anyone help me with a question. My problem is I have a positive result from ELISA and a background result. I would like to subtract my background result from the positive result. These are two means of an average of two wells. I would like to take into account in this calculation the deviation within each mean, for the positive and negative results, so as to have a more representative result of the variation. This I would like to do by weighting the resulting value from the subtraction of the two means by the standard deviation (or error of the two means). Is such a calculation possible. Is this clear !!!!!! I hope so statistics is not my field. Thanks for any possible ideas. Luke Scicluna Luke.Scicluna@ivi.admin.ch -- NewsGrazer, a NeXTstep(tm) news reader, posting -- M>UQR=&8P7&%N#$Q-3)<='@R,S`T7'1X,S0U-EQT M>#0V,#A<='@U-S8P7'1X-CDQ,EQT>#@P-C1<='@Y,C$V7'1X,3`S-CA<='@Q M,34R,%QF,%QB,%QI,%QU;&YO;F5<9G,R-%QF8S!<8V8P($-O=6QD(&%N>6]N M92!H96QP(&UE('=I=&@@82!Q=65S=&EO;BY<"@E->2!P2!T:&4@ NNTP-Posting-Host: net.bio.net I'm sure most diagnosticians/pathologists believe/know that early diagnosis of a pest / pathogen / disease is advantageous for a grower as he/she can take control measures and minimise losses. But, I am interested in finding SPECIFIC EXAMPLES that early diagnosis of a pest/disease/pathogen in a crop can lead to harm minimisation and a consequential improved yield. In particular I am looking for some cases where it can be shown that the earlier the diagnosis the better the yield. Does anyone know where I can get some good statistics about this? James Miller Scientist Agriculture Victoria Australia 61 3 9210 9252 *********************************************** James Miller Agriculture Victoria Institute for Horticultural Development Knoxfield Private Bag 15 South Eastern Mail Centre Victoria 3176 ****************************************** Ph-(03) 9210 9252 (o o) FAX- (03) 9800 3521 ( O ) **************************oOO*****OOo***** From owner-diagnostics@net.bio.net Sun Jun 16 23:00:00 1996 Path: biosci!ihnp4.ucsd.edu!munnari.OZ.AU!news.mel.connect.com.au!harbinger.cc.monash.edu.au!nntp.coast.net!howland.reston.ans.net!news-e2a.gnn.com!newstf01.news.aol.com!newsbf02.news.aol.com!not-for-mail From: rmeader726@aol.com (RMeader726) Newsgroups: bionet.diagnostics Subject: DiagnosisPro software new WEB page Date: 17 Jun 1996 19:08:37 -0400 Organization: America Online, Inc. (1-800-827-6364) Lines: 6 Sender: root@newsbf02.news.aol.com Message-ID: <4q4ohl$2en@newsbf02.news.aol.com> Reply-To: rmeader726@aol.com (RMeader726) NNTP-Posting-Host: newsbf02.mail.aol.com DiagnosisPro (was Remind4) software now has a new WEB page at: 'http://home.aol.com/RMeader726' Come visit us or get on our mailing list. Charles Meader, MD/Co-author From owner-diagnostics@net.bio.net Sun Jun 16 23:00:00 1996 Newsgroups: bionet.biophysics,bionet.diagnostics,sci.med.radiology.interventional,sci.engr.biomed,soc.culture.german,sci.image.processing,comp.lang.pascal.delphi.misc,alt.lang.delphi,sci.physics.electromag,sci.techniques.mag-resonance,sci.med.physics,sc Path: biosci!daresbury!yama.mcc.ac.uk!thor.cf.ac.uk!news From: schneider@cf.ac.uk Subject: Electrical Impedance Tomography - new W3 page Sender: news@cf.ac.uk (USENET News System) Message-ID: Date: Mon, 17 Jun 1996 19:13:05 GMT X-Nntp-Posting-Host: d106.elsy.cf.ac.uk Reply-To: schneider@cf.ac.uk Organization: Heaven X-Newsreader: WinVN 0.92.6+ Lines: 7 Xref: biosci bionet.biophysics:2124 bionet.diagnostics:911 sci.med.radiology.interventional:106 sci.engr.biomed:6312 soc.culture.german:84748 sci.image.processing:20661 comp.lang.pascal.delphi.misc:43023 sci.physics.electromag:11051 sci.techniques.mag-resonance:1689 sci.med.physics:4462 A new biomedical orientated webpage focussing Electrical Impedance Tomography (EIT) can be found at http://www.cf.ac.uk/uwcc/engin/Systems/medical/ingo/ingo.html Feedback or not links to not listed sites are welcome. Ingo From owner-diagnostics@net.bio.net Mon Jun 17 23:00:00 1996 Path: biosci!ihnp4.ucsd.edu!munnari.OZ.AU!news.mel.connect.com.au!harbinger.cc.monash.edu.au!nntp.coast.net!oleane!jussieu.fr!unilim.fr!cict.fr!news From: J-F Magnaval Newsgroups: bionet.diagnostics Subject: Re: Straw Poll Results Date: Tue, 18 Jun 1996 09:09:08 -0700 Lines: 12 Message-ID: <31C6D4A4.3541@cict.fr> References: <9606141610.aa13643@jura.sasa.gov.uk> NNTP-Posting-Host: magnaval.cict.fr Mime-Version: 1.0 Content-Type: text/plain; charset=iso-8859-1 Content-Transfer-Encoding: 8bit X-Mailer: Mozilla 2.0 (Win16; I) Kevin O'Donnell wrote: > > The straw poll has already generated 20 votes for moderation and only HURRAH!!!! -- Jean-François Magnaval, MD, DSc. Lab. Parasitologie CHU Purpan 31059 Toulouse France Phone 33 61 77 20 12 Fax 33 61 77 23 78 From owner-diagnostics@net.bio.net Mon Jun 17 23:00:00 1996 Path: biosci!rutgers!gatech!usenet.eel.ufl.edu!psgrain!iafrica.com!peacenjoy.mikom.csir.co.za!callisto.cids.org.za!usenet From: Kabelo Bosilong <11177@stalban.pta.schools.za> Newsgroups: bionet.diagnostics Subject: test Date: Tue, 18 Jun 1996 12:07:37 -0700 Organization: The CIDS News Server Lines: 1 Message-ID: <31C6FE79.5E29@stalban.pta.schools.za> NNTP-Posting-Host: 196.13.125.21 Mime-Version: 1.0 Content-Type: text/plain; charset=us-ascii Content-Transfer-Encoding: 7bit X-Mailer: Mozilla 2.01 (Win16; I) Just testin' From owner-diagnostics@net.bio.net Mon Jun 17 23:00:00 1996 Path: biosci!rutgers!gatech!usenet.eel.ufl.edu!psgrain!iafrica.com!peacenjoy.mikom.csir.co.za!callisto.cids.org.za!usenet From: Kabelo Bosilong <11177@stalban.pta.schools.za> Newsgroups: bionet.diagnostics Subject: test Date: Tue, 18 Jun 1996 12:07:07 -0700 Organization: The CIDS News Server Lines: 1 Message-ID: <31C6FE5B.3CE4@stalban.pta.schools.za> NNTP-Posting-Host: 196.13.125.21 Mime-Version: 1.0 Content-Type: text/plain; charset=us-ascii Content-Transfer-Encoding: 7bit X-Mailer: Mozilla 2.01 (Win16; I) Just testin' From owner-diagnostics@net.bio.net Mon Jun 17 23:00:00 1996 Path: biosci!agate!howland.reston.ans.net!newsfeed.internetmci.com!news.kei.com!nntp.coast.net!netnews.worldnet.att.net!newsadm From: ptravis@super.zippo.com (Anybody) Newsgroups: bionet.diagnostics,bionet.microbiology,sci.bio.microbiology,sci.bio.technology Subject: Any experience w/ Gen-Probe's new TB detecting system Date: Tue, 18 Jun 1996 13:38:10 GMT Organization: AT&T WorldNet Services Lines: 12 Distribution: inet Message-ID: <31c6b075.35526788@netnews.worldnet.att.net> NNTP-Posting-Host: 142.houston-1.tx.dial-access.att.net X-Newsreader: Forte Agent .99d/32.182 Xref: biosci bionet.diagnostics:920 bionet.microbiology:6368 sci.bio.microbiology:3654 sci.bio.technology:5606 I was wondering if anyone out there has had any experience or opinions on the new amplification system (TMA) developed by Gen-Probe Inc. in San Diego for detecting Turborculosis (TB). Supposedly you can get a result in less than 4 hours. Any post regarding this and how it compares to other methods would be appreciated. Post them here for everyone to benefit. Thank in advance Pass From owner-diagnostics@net.bio.net Mon Jun 17 23:00:00 1996 Path: biosci!rutgers!uwm.edu!vixen.cso.uiuc.edu!newsfeed.internetmci.com!in2.uu.net!netnews.worldnet.att.net!ix.netcom.com!news From: Dan Tisone Newsgroups: bionet.diagnostics Subject: test Date: Tue, 18 Jun 1996 06:24:02 -0700 Organization: Netcom Lines: 1 Message-ID: <31C6ADF2.3415@ix.netcom.com> NNTP-Posting-Host: irv-ca16-12.ix.netcom.com Mime-Version: 1.0 Content-Type: text/plain; charset=us-ascii Content-Transfer-Encoding: 7bit X-NETCOM-Date: Tue Jun 18 6:18:35 AM PDT 1996 X-Mailer: Mozilla 2.02Gold (Win95; I) test From owner-diagnostics@net.bio.net Mon Jun 17 23:00:00 1996 Path: biosci!rutgers!uwm.edu!math.ohio-state.edu!howland.reston.ans.net!swrinde!newsfeed.internetmci.com!in2.uu.net!netnews.worldnet.att.net!ix.netcom.com!news From: Dan Tisone Newsgroups: bionet.diagnostics,sci.chem,sci.med,sci.bio.technology,bionet.general Subject: India Sales Rep Needed Date: Tue, 18 Jun 1996 06:23:24 -0700 Organization: Netcom Lines: 6 Distribution: inet Message-ID: <31C6ADCC.371C@ix.netcom.com> NNTP-Posting-Host: irv-ca16-12.ix.netcom.com Mime-Version: 1.0 Content-Type: text/plain; charset=us-ascii Content-Transfer-Encoding: 7bit X-NETCOM-Date: Tue Jun 18 6:17:57 AM PDT 1996 X-Mailer: Mozilla 2.02Gold (Win95; I) Xref: biosci bionet.diagnostics:918 sci.chem:58705 sci.med:128035 sci.bio.technology:5605 bionet.general:22362 I work for a company who manufacturers equipment for the rapid diagnostic industry. We are currently looking for a sales representative who is familiar with the market in India. All interested parties please contact me for more detailed information. Dan Tisone From owner-diagnostics@net.bio.net Mon Jun 17 23:00:00 1996 Path: biosci!sasa.gov.uk!burns From: burns@sasa.gov.uk (Robert Burns) Newsgroups: bionet.diagnostics Subject: Dupytron contracture Date: 18 Jun 1996 08:00:39 -0700 Organization: BIOSCI International Newsgroups for Molecular Biology Lines: 26 Sender: daemon@net.bio.net Distribution: world Message-ID: NNTP-Posting-Host: net.bio.net Hi all, I was asked by a friend to find out some information on the diagnosis and treatment of Dupytron contracture. Having failed elsewhere I thought I would ask you lot! I know that this does not fall strictly within our" diagnostic " remit but if anybody has some info or some pointers to info I would be grateful to hear directly to me via Email. Rob Robert Burns Monoclonal Antibody Unit Scottish Agricultural Science Agency East Craigs Edinburgh Scotland burns@sasa.gov.uk From owner-diagnostics@net.bio.net Tue Jun 18 23:00:00 1996 From: jjmacey@msn.com (john macey) Subject: Resume: Asia Regional Biotech / Biomedical Manager Date: 19 Jun 96 12:39:27 -0700 Message-ID: <00005ae5+000001e3@msn.com> Path: biosci!bcm.tmc.edu!cs.utexas.edu!howland.reston.ans.net!newsfeed.internetmci.com!news.sprintlink.net!new-news.sprintlink.net!news.msn.com!msn.com Newsgroups: bionet.diagnostics Organization: The Microsoft Network (msn.com) Lines: 122 Dear Employment Executive, I am presently searching for an operational management position in the life science field dealing in either the capital equipment or biotech / biomedical areas based in the Asia-Pacific region, preferably in either Singapore or Kuala Lumpur, Malaysia. In terms of career accomplishments I have the following to offer: · Progressive up-todate track record in the fields of immunology, toxicology, molecular biology, laboratory instrumentation and reagents and medical technologies. · Proven sales and marketing management success at some of the major players in the medical industry in positions of high visibility. · Ability to adapt to any international business development environment. · Extensive experience with capital equipment. More importantly I can bring the following career experiences: · Knowledge of the Asia market in terms of trends, channels of distribution and cultural differences. · Trained and knowledgeable in most aspects of the biosciences. · Fully skilled in sales, marketing and most aspects of management related to field operations. · Willingness to travel, work independently, but within a team, to reach common goals and objectives · Management experience in the areas of distributor maintenance and acquisition. Objective Operational management position in the medical / life sciences field working to develop the business potential in the greater Asia-Pacific region. Professional Experience HUMAN BIOCHEMICALS & DIAGNOSTICS, Asia Business Development Manager - Taunusstein, Germany Clinical Laboratory products (clinical chemistry, immunochemistry, coagulation, instrumentation, rapid tests), OEM reagents to the diagnostics industry and over the counter (OTC) products. Charged with distributor acquisition and management, strategic business partnership development, product training or product development for the three different business strategies. 1995 - Present. ROCHE DIAGNOSTIC SYSTEMS, Regional Marketing Manager - Asia, Kuala Lumpur, Malaysia Immunochemistry, Toxicology, Molecular Diagnostics (Polymerase Chain Reaction - PCR) and associated instrumentation. Direct responsibilities are to train customers, distributors, regional Roche personnel, provide technical support, educate and develop the product potential in 9 countries on the Asia-Pacific region. Reporting activity are to three business units, either European, US and the Swiss headquarters point. Measurable success has been directly related to 5 year business and marketing plan development, extensive travel to customer sites, professional medical speakership, product related symposia and trade show organization. Direct reports : 3. 1991 - 1995. ROCHE DIAGNOSTIC SYSTEMS, Immunochemistry Business Unit Marketing Manager, Basle, Switzerland Immunochemistry Instruments and Reagents. Position demanded development of all elements related to product support and introductions on a global basis. Support was internally directed at Roche personnel or distributors to guarantee that sales targets and goals were met to maximize product potential. Direct reports : 7. 1989 - 1991 ABBOTT DIAGNOSTICS DIVISION, Area Strategy Manager - Europe, Middle-East & Africa (EME&A), Wiesbaden, Germany Laboratory Instrumentation and Reagents. Keys to success were formulated strategic plans, pricing, marketing plan development and implementation, as well as promotional efforts throughout EME&A. Position required extensive travel to the Abbott European affiliates to support and conceive local marketing plans and activities - based upon local requirements - and in-line with overall corporate goals and objectives. 1986 - 1989. Previous experience in In-Vitro and In-Vivo (radio-pharmaceutical) diagnostics - DuPont / New England Nuclear - Dreieich, Germany, European Product Manager, 1980 - 1985. Education American University, Washington, DC MBA Candidate Economics/Statistics Widener University, Chester, Pa, - Marketing/Business Management St. Joseph’s University, Phil, PA - B SC Bio-Chemistry Personal Working knowledge of most Microsoft Windows 95 applications (Word, Excel, Powerpoint), IBM (OS2 Internet Connections - Gopher, WWW, email) and Harvard Graphics computer applications related to business management. Have been trained in professional selling skills, marketing and financial management. American citizenship, married, fluent spoken German. References Excellent international professional and personal references can be supplied upon request. World Wide Web http://conquest-prod.iserver.com/jobnetwork/resumesubmit/ messages/1379.html From owner-diagnostics@net.bio.net Tue Jun 18 23:00:00 1996 Path: biosci!SCRI.SARI.AC.UK!djones From: djones@SCRI.SARI.AC.UK (D Jones) Newsgroups: bionet.diagnostics Subject: Re: early diagnosis = money? Date: 19 Jun 1996 08:30:05 -0700 Organization: BIOSCI International Newsgroups for Molecular Biology Lines: 8 Sender: daemon@net.bio.net Distribution: world Message-ID: <199606191526.QAA24910@caird.scri.sari.ac.uk> NNTP-Posting-Host: net.bio.net One thing I can think of, but I'm not sure whether you are or not, is the practice of roguing seed potato crops, thus ridding the crop of further virus sources. Someone makes a diagnosis based on visual symptoms and removes the infected plant. Whether there are any reports on how this affects yield or not - I haven't a clue, though I suspect that anything that has been published is probably prewar. It's been going on a long time! Dave From owner-diagnostics@net.bio.net Wed Jun 19 23:00:00 1996 Path: biosci!rutgers!uwm.edu!math.ohio-state.edu!howland.reston.ans.net!ixnews1.ix.netcom.com!ix.netcom.com!ix.netcom.com!news From: Dan Tisone Newsgroups: bionet.diagnostics,bionet.general,sci.bio.technology,sci.med,sci.chem Subject: India Sales Rep Needed Date: Wed, 19 Jun 1996 19:05:04 -0700 Organization: Netcom Lines: 6 Distribution: inet Message-ID: <31C8B1D0.41B2@ix.netcom.com> NNTP-Posting-Host: irv-ca10-21.ix.netcom.com Mime-Version: 1.0 Content-Type: text/plain; charset=us-ascii Content-Transfer-Encoding: 7bit X-NETCOM-Date: Wed Jun 19 8:59:37 PM CDT 1996 X-Mailer: Mozilla 2.02Gold (Win95; I) Xref: biosci bionet.diagnostics:926 bionet.general:22399 sci.bio.technology:5615 sci.med:128275 sci.chem:58822 I work for a company who manufacturers equipment for the rapid diagnostic industry. We are currently looking for a sales representative who is familiar with the market in India. All interested parties please contact me for more detailed information. Dan Tisone From owner-diagnostics@net.bio.net Wed Jun 19 23:00:00 1996 Path: biosci!aol.com!MHughes77 From: MHughes77@aol.com Newsgroups: bionet.diagnostics Subject: Looking for Lupin Labs Date: 19 Jun 1996 17:23:16 -0700 Organization: BIOSCI International Newsgroups for Molecular Biology Lines: 6 Sender: daemon@net.bio.net Distribution: world Message-ID: <960619201933_417700587@emout14.mail.aol.com> NNTP-Posting-Host: net.bio.net Diagnostics Newsgroup members: I would like to locate a diagnostics test kit manufacturer called "Lupin Labs" or something similar. Any leads would be appreciated. Mark From owner-diagnostics@net.bio.net Wed Jun 19 23:00:00 1996 Path: biosci!rutgers!gatech!usenet.eel.ufl.edu!arclight.uoregon.edu!chi-news.cic.net!news.compuserve.com!news.production.compuserve.com!news From: Margaret Fowler <101722.35@CompuServe.COM> Newsgroups: bionet.diagnostics Subject: Gilbert Ling Date: 20 Jun 1996 10:06:45 GMT Organization: CompuServe, Inc. (1-800-689-0736) Lines: 5 Message-ID: <4qb7rl$qrn$1@mhafc.production.compuserve.com> Does anyone know where Gilbert Ling (I think e.g. inventor of intracellular electrodes) is and/or if he's on Internet or USenet? Thanks. Rae West. From owner-diagnostics@net.bio.net Wed Jun 19 23:00:00 1996 Path: biosci!daresbury!nntp-trd.UNINETT.no!Norway.EU.net!nntp.uio.no!news.cais.net!chi-news.cic.net!news.compuserve.com!news.production.compuserve.com!news From: Eric Masseus <100577.3707@CompuServe.COM> Newsgroups: bionet.diagnostics,bionet.diagnostics.prenatal,sci.med.immunology,sci.med.laboratory Subject: Conference on Quality [R]evolution. Date: 20 Jun 1996 12:38:24 GMT Organization: Gooi-Noord Hospital, Dept Clin Chem, Netherlands Lines: 11 Message-ID: <4qbgo0$6m5$1@mhadf.production.compuserve.com> Xref: biosci bionet.diagnostics:928 bionet.diagnostics.prenatal:166 sci.med.immunology:6717 sci.med.laboratory:1580 Information about the Second European Conference on Quality [R]evolution in Clinical Laboratories guidelines practical implementation of quality management. Elzenveld Congrescenter, Antwerp, Belgium on 27-28 October 1996. can be found via my web pages: http://ourworld.compuserve.com/homepages/Eric_Masseus_eforum Eric Masseus 100577.3707@compuserve.com From owner-diagnostics@net.bio.net Thu Jun 20 23:00:00 1996 Path: biosci!rutgers!sgigate.sgi.com!swrinde!newsfeed.internetmci.com!in2.uu.net!news.ios.com!usenet From: KrisPrasad Newsgroups: bionet.diagnostics Subject: Re: Looking for Lupin Labs Date: 21 Jun 1996 03:29:16 GMT Organization: Internet Online Services Lines: 10 Message-ID: <4qd4uc$hhm@news.ios.com> References: <960619201933_417700587@emout14.mail.aol.com> NNTP-Posting-Host: ppp-1.ts-10.hck.idt.net Mime-Version: 1.0 Content-Type: text/plain; charset=us-ascii Content-Transfer-Encoding: 7bit X-Mailer: Mozilla 1.2 (Windows; U; 16bit) To: MHughes77@aol.com Try the following: 1. Lupin Labs, Bombay, India 2. Lupin Labs, Bhopal, MP, India Sorry, do not have the exact address. KP From owner-diagnostics@net.bio.net Thu Jun 20 23:00:00 1996 From: jjmacey@msn.com (john macey) Subject: Asia Biotech / Biomedical Manager: Resume (John J. Macey) Date: 21 Jun 96 12:41:30 -0700 Message-ID: <00005ae5+000001e5@msn.com> Path: biosci!bcm.tmc.edu!cs.utexas.edu!howland.reston.ans.net!newsfeed.internetmci.com!in2.uu.net!newsflash.concordia.ca!newsfeed.pitt.edu!godot.cc.duq.edu!newsgate.duke.edu!interpath!news.sprintlink.net!news-fw-12.sprintlink.net!news.msn.com!msn.com Newsgroups: bionet.diagnostics Organization: The Microsoft Network (msn.com) Lines: 122 Dear Employment Executive, I am presently searching for an operational management position in the life science field dealing in either the capital equipment or biotech / biomedical areas based in the Asia-Pacific region, preferably in either Singapore or Kuala Lumpur, Malaysia. In terms of career accomplishments I have the following to offer: · Progressive up-todate track record in the fields of immunology, toxicology, molecular biology, laboratory instrumentation and reagents and medical technologies. · Proven sales and marketing management success at some of the major players in the medical industry in positions of high visibility. · Ability to adapt to any international business development environment. · Extensive experience with capital equipment. More importantly I can bring the following career experiences: · Knowledge of the Asia market in terms of trends, channels of distribution and cultural differences. · Trained and knowledgeable in most aspects of the biosciences. · Fully skilled in sales, marketing and most aspects of management related to field operations. · Willingness to travel, work independently, but within a team, to reach common goals and objectives · Management experience in the areas of distributor maintenance and acquisition. Objective Operational management position in the medical / life sciences field working to develop the business potential in the greater Asia-Pacific region. Professional Experience HUMAN BIOCHEMICALS & DIAGNOSTICS, Asia Business Development Manager - Taunusstein, Germany Clinical Laboratory products (clinical chemistry, immunochemistry, coagulation, instrumentation, rapid tests), OEM reagents to the diagnostics industry and over the counter (OTC) products. Charged with distributor acquisition and management, strategic business partnership development, product training or product development for the three different business strategies. 1995 - Present. ROCHE DIAGNOSTIC SYSTEMS, Regional Marketing Manager - Asia, Kuala Lumpur, Malaysia Immunochemistry, Toxicology, Molecular Diagnostics (Polymerase Chain Reaction - PCR) and associated instrumentation. Direct responsibilities are to train customers, distributors, regional Roche personnel, provide technical support, educate and develop the product potential in 9 countries on the Asia-Pacific region. Reporting activity are to three business units, either European, US and the Swiss headquarters point. Measurable success has been directly related to 5 year business and marketing plan development, extensive travel to customer sites, professional medical speakership, product related symposia and trade show organization. Direct reports : 3. 1991 - 1995. ROCHE DIAGNOSTIC SYSTEMS, Immunochemistry Business Unit Marketing Manager, Basle, Switzerland Immunochemistry Instruments and Reagents. Position demanded development of all elements related to product support and introductions on a global basis. Support was internally directed at Roche personnel or distributors to guarantee that sales targets and goals were met to maximize product potential. Direct reports : 7. 1989 - 1991 ABBOTT DIAGNOSTICS DIVISION, Area Strategy Manager - Europe, Middle-East & Africa (EME&A), Wiesbaden, Germany Laboratory Instrumentation and Reagents. Keys to success were formulated strategic plans, pricing, marketing plan development and implementation, as well as promotional efforts throughout EME&A. Position required extensive travel to the Abbott European affiliates to support and conceive local marketing plans and activities - based upon local requirements - and in-line with overall corporate goals and objectives. 1986 - 1989. Previous experience in In-Vitro and In-Vivo (radio-pharmaceutical) diagnostics - DuPont / New England Nuclear - Dreieich, Germany, European Product Manager, 1980 - 1985. Education American University, Washington, DC MBA Candidate Economics/Statistics Widener University, Chester, Pa, - Marketing/Business Management St. Joseph’s University, Phil, PA - B SC Bio-Chemistry Personal Working knowledge of most Microsoft Windows 95 applications (Word, Excel, Powerpoint), IBM (OS2 Internet Connections - Gopher, WWW, email) and Harvard Graphics computer applications related to business management. Have been trained in professional selling skills, marketing and financial management. American citizenship, married, fluent spoken German. References Excellent international professional and personal references can be supplied upon request. World Wide Web http://conquest-prod.iserver.com/jobnetwork/resumesubmit/ messages/1379.html From owner-diagnostics@net.bio.net Thu Jun 20 23:00:00 1996 Path: biosci!mail.biogen.com!Tom_Parish From: Tom_Parish@mail.biogen.com (Tom Parish) Newsgroups: bionet.diagnostics Subject: Synperonic (PE/F68) Date: 21 Jun 1996 13:42:09 -0700 Organization: BIOSCI International Newsgroups for Molecular Biology Lines: 9 Sender: daemon@net.bio.net Distribution: world Message-ID: <9606211933.AA0245@worldcom-45.worldcom.com> NNTP-Posting-Host: net.bio.net Hi, Does anyone know where I can purchase Synperonic? It is made by ICI in England but I can't find it in the U.S. In addition has anyone had any success using this reagent in an ELISA to reduce nonspecific antibody binding interactions? Any help would be appreciated. From owner-diagnostics@net.bio.net Sun Jun 23 23:00:00 1996 Path: biosci!bcm.tmc.edu!cs.utexas.edu!howland.reston.ans.net!surfnet.nl!swsbe6.switch.ch!scsing.switch.ch!elna.ethz.ch!inf.ethz.ch!news From: Gian Carle Newsgroups: bionet.diagnostics Subject: Internet Environment Survey Date: Mon, 24 Jun 1996 12:22:54 +0200 Organization: ETH Zuerich Lines: 48 Message-ID: <31CE6C7E.4F28@uns.umnw.ethz.ch> NNTP-Posting-Host: kyu8.inf.ethz.ch Mime-Version: 1.0 Content-Type: text/plain; charset=us-ascii Content-Transfer-Encoding: 7bit X-Mailer: Mozilla 2.02 (Macintosh; I; 68K) Thats an announcement and not the questionnaire itself !!!! ENVIRONMENTAL Internet SURVEY http://www.umnw.ethz.ch/Students/survey/welcome.html University term paper in the field of Social Studies " Media and Public Work in Science and Environmental Protection" I am currently working on the University term pater "Internet and Environment". Our aim is to establish the manner in which the Internet is uses by people interested in environmental issues. 1.What is the quality rating of environmental information? 2.How userfriendly is the Internet in the fields of environment and ecology? 3.Which are your requirements in the field of environmental issues? 4.Where do you see problems in this respect? Please take around 10 minutes to answer the questionnaire on the following page. Thank you for transmitting this link to your environmental colleagues. english version: http://www.umnw.ethz.ch/Students/survey/welcome.html Deutsche Version: http://www.umnw.ethz.ch/Students/survey/welcomeg.html Version francaise: http://www.umnw.ethz.ch/Students/survey/welcomef.html Thank you very much for your help and for filling out the survey. Please fill-it also out if some questions are too difficult to answer for you!!! Gian Carle carle@uns.umnw.ethz.ch From owner-diagnostics@net.bio.net Mon Jun 24 23:00:00 1996 Path: biosci!bcm.tmc.edu!cs.utexas.edu!howland.reston.ans.net!vixen.cso.uiuc.edu!news.uoregon.edu!arclight.uoregon.edu!enews.sgi.com!su-news-feed4.bbnplanet.com!news1.slip.net!news From: seapilot@slip.net (seapilot) Newsgroups: bionet.diagnostics Subject: firstenberg.com for used diagnostic equipment Date: Mon, 24 Jun 1996 23:53:30 GMT Organization: Slip.Net Lines: 4 Message-ID: <4qna24$8a0@news1.slip.net> NNTP-Posting-Host: sf-asc-78-226.dialup.slip.net X-Newsreader: Forte Free Agent v0.55 If you have surplus diagnostic equipment for sale or need to find good pre-owned machinery for diagnostics check out the home page at http://firstenberg.com From owner-diagnostics@net.bio.net Tue Jun 25 23:00:00 1996 Path: biosci!daresbury!nntp-trd.UNINETT.no!Norway.EU.net!nntp.uio.no!news.cais.net!nntp.primenet.com!news.mathworks.com!newsfeed.internetmci.com!news.compuserve.com!newsmaster From: 101756.1557@compuserve.com (Hans Molijn) Newsgroups: bionet.diagnostics,bionet.virology,sci.med.diseases.hepatitis,sci.med.laboratory Subject: Multi marker virology controls Date: Wed, 26 Jun 1996 06:24:38 GMT Organization: Red Cross Blood Bank Lines: 38 Expires: 31 Jul 1996 Message-ID: <4qqip1$nkp@arl-news-svc-2.compuserve.com> NNTP-Posting-Host: dd45-234.compuserve.com X-Newsreader: Forte Free Agent 1.0.82 Xref: biosci bionet.diagnostics:938 bionet.virology:7303 sci.med.diseases.hepatitis:1516 sci.med.laboratory:1614 Our laboratory is using a fully automated virology batch analyser (PRISM; Abbott Diagnostics) for the detection of: - HBsAg - anti-HBc - anti-HIV1/2 - anti-HCV - anti-HTLV-I/II. We are using a commerial avalilable multi marker "spy" sample for the assays above (accept for anti-HBC). This spy is used as an unkown sample in the daily routine. After every 100 tubes a release and a spy control is used. We like to use a quality control sample other than provided by the reagent company to find any differences in time or from batch to batch. An insert gives all the measurements of all assays used with this controls. Every new batch give updated data. In this way we can compare our QC data with other laboratories. On INTERNET is not much data availlable about "in-line" quality control samples. If there is any data available please let me know. I'm looking for other multi-marker controls with the same organisation as the controls we use now. questions: - are they available, if yes where? - prices? If you want to have any information about the QC controls we use please let me know. As far as I know there are other QC controls available for other assays (TPHA) and techniques (PCR). If you want you can reply on my E-mail address: 101756.1557@compuserve.com M.H.J. Molijn E-mail: 101756.1557@compuserve.com From owner-diagnostics@net.bio.net Tue Jun 25 23:00:00 1996 Path: biosci!daresbury!nntp-trd.UNINETT.no!Norway.EU.net!EU.net!enews.sgi.com!su-news-feed4.bbnplanet.com!news1.slip.net!news From: Tom@firstenberg.com (Tom) Newsgroups: bionet.diagnostics Subject: Alcohol Storage Tanks available for sale Date: Wed, 26 Jun 1996 17:48:58 GMT Organization: Firstenberg Machinery Lines: 5 Message-ID: <4qrtds$k5l@news1.slip.net> NNTP-Posting-Host: sf-asc-78-226.dialup.slip.net X-Newsreader: Forte Free Agent v0.55 Available for immediate sale: (2) DCI 304 stainless steel 4000 gallon horizontal alcohol storage tanks. Includes nitrogen gas system. New in 1991. Contact Tom at firstenberg.com or phone at 510-233-7777. Fax 510-236-9685 From owner-diagnostics@net.bio.net Wed Jun 26 23:00:00 1996 Path: biosci!bcm.tmc.edu!cs.utexas.edu!swrinde!howland.reston.ans.net!news-e2a.gnn.com!newstf01.news.aol.com!newsbf02.news.aol.com!not-for-mail From: sky406@aol.com (Sky406) Newsgroups: bionet.diagnostics Subject: GRAPHICS DESIGNER Date: 27 Jun 1996 13:42:12 -0400 Organization: America Online, Inc. (1-800-827-6364) Lines: 13 Sender: root@newsbf02.news.aol.com Message-ID: <4quh5k$s73@newsbf02.news.aol.com> Reply-To: sky406@aol.com (Sky406) NNTP-Posting-Host: newsbf02.mail.aol.com National Diagnostics, an international biotechnology company based in Atlanta, GA, is seeking a graphics designer. Self-starter able to develop creative advertising campaigns. Biology/Life Science or Graphic Design degree preferred. MAC or PC skills essential. Experience with Pagemaker a plus. 1 to 2 years experience. Full time, salary 21k+bonuses and benefits. Interested candidates should send or fax resumes to the attention of Ms. Tracy Walters at: National Diagnostics 305 Patton Drive Atlanta, GA 30336 fax: (404) 699-2077 From owner-diagnostics@net.bio.net Wed Jun 26 23:00:00 1996 Path: biosci!rutgers!uwm.edu!vixen.cso.uiuc.edu!newsfeed.internetmci.com!news.sprintlink.net!news-stk-200.sprintlink.net!news.sprintlink.net!news-stk-11.sprintlink.net!news.dgsys.com!kpl From: Mblank@kpl.com (Martin Blankfard) Newsgroups: bionet.diagnostics Subject: Jobs! Date: 26 Jun 1996 18:52:42 GMT Organization: KPL Lines: 9 Message-ID: <4qs0mn$sco_001@dgs.dgsys.com> NNTP-Posting-Host: kpl.com Summary: Production, Lab X-Newsreader: News Xpress Version 1.0 Beta #4 Kirkegaard & Perry Labs, a leading producer of immunological reagents, has two openings in Manufacturing. One is in the Antibody Purification Group, and requires B.S. in Biology or Chemistry and 3-5 years experience in protein purification in a manufacturing environment. The other is in the Conjugation/Solution Group, and requires B.S. Bio./Chem. with 2-4 years experience in antibody/protein conjugation in a manufacturing setting. Experience in ELISA, RID, GMP a plus. KPL is an equal opportunity employer and offers an excellent benefits package. Please send resumes to: Human Resources, 2 Cessna Court, Gaithersburg, MD 20879. From owner-diagnostics@net.bio.net Wed Jun 26 23:00:00 1996 Path: biosci!bcm.tmc.edu!cs.utexas.edu!swrinde!howland.reston.ans.net!news-e2a.gnn.com!newstf01.news.aol.com!newsbf02.news.aol.com!not-for-mail From: sky406@aol.com (Sky406) Newsgroups: bionet.diagnostics Subject: SALES/MANUFACTURERS REPRESENTATIVE Date: 27 Jun 1996 14:07:22 -0400 Organization: America Online, Inc. (1-800-827-6364) Lines: 14 Sender: root@newsbf02.news.aol.com Message-ID: <4quikq$stg@newsbf02.news.aol.com> Reply-To: sky406@aol.com (Sky406) NNTP-Posting-Host: newsbf02.mail.aol.com National Diagnostics, an international biotechnology company based in Atlanta, Georgia, is seeking sales representatives for the following regions: Northern California; Washington State; Chicago; Minneapolis; Alabama, Georgia, Florida. Life Science degree and lab experience with knowledge of electrophoresis, scintillation counting, and immunology required. Some prior sales experience preferred. High commission compensation basis. Interested candidates should send or fax resumes to the attention of Ms. K. Hennessy at: National Diagnostics 305 Patton Drive Atlanta, GA 30336 fax: (404) 699-2077 From owner-diagnostics@net.bio.net Wed Jun 26 23:00:00 1996 Path: biosci!bcm.tmc.edu!cs.utexas.edu!swrinde!howland.reston.ans.net!news-e2a.gnn.com!newstf01.news.aol.com!newsbf02.news.aol.com!not-for-mail From: sky406@aol.com (Sky406) Newsgroups: bionet.diagnostics Subject: TECHNICAL SERVICES / MARKETING Date: 27 Jun 1996 14:13:04 -0400 Organization: America Online, Inc. (1-800-827-6364) Lines: 21 Sender: root@newsbf02.news.aol.com Message-ID: <4quivg$t3o@newsbf02.news.aol.com> Reply-To: sky406@aol.com (Sky406) NNTP-Posting-Host: newsbf02.mail.aol.com National Diagnostics, a manufacturer and international marketer of electrophoresis chemicals, liquid scintillation and histology products is seeking a Technical Services Representative whose responsibilities will include: -Answering customer technical questions -Support for domestic sales force -Trade Show organization, attendance and follow-up -Press release and Advertising production The qualified candidate will have expertise in molecular biology including nucleic acid purification, electrophoresis and sequencing; protein purification, detection and electrophoresis; and excellent communication and computer skills. Interested candidates should send or fax resume to the attention of Ms. K. Hennessy at: National Diagnostics 305 Patton Drive Atlanta, GA 30336 fax: (404) 699-2077 From owner-diagnostics@net.bio.net Fri Jun 28 23:00:00 1996 From: jjmacey@msn.com (john macey) Subject: Resume: Asia Biotech / Biomedical Manager (J.J. Macey) Date: 29 Jun 96 03:41:00 -0700 Message-ID: <00005ae5+000001e8@msn.com> Path: biosci!rutgers!netnews.upenn.edu!dsinc!newsfeed.pitt.edu!godot.cc.duq.edu!newsgate.duke.edu!interpath!news.sprintlink.net!news-fw-12.sprintlink.net!news.msn.com!msn.com Newsgroups: bionet.diagnostics Organization: The Microsoft Network (msn.com) Lines: 122 Dear Employment Executive, I am presently searching for an operational management position in the life science field dealing in either the capital equipment or biotech / biomedical areas based in the Asia-Pacific region, preferably in either Singapore or Kuala Lumpur, Malaysia. In terms of career accomplishments I have the following to offer: · Progressive up-todate track record in the fields of immunology, toxicology, molecular biology, laboratory instrumentation and reagents and medical technologies. · Proven sales and marketing management success at some of the major players in the medical industry in positions of high visibility. · Ability to adapt to any international business development environment. · Extensive experience with capital equipment. More importantly I can bring the following career experiences: · Knowledge of the Asia market in terms of trends, channels of distribution and cultural differences. · Trained and knowledgeable in most aspects of the biosciences. · Fully skilled in sales, marketing and most aspects of management related to field operations. · Willingness to travel, work independently, but within a team, to reach common goals and objectives · Management experience in the areas of distributor maintenance and acquisition. Objective Operational management position in the medical / life sciences field working to develop the business potential in the greater Asia-Pacific region. Professional Experience HUMAN BIOCHEMICALS & DIAGNOSTICS, Asia Business Development Manager - Taunusstein, Germany Clinical Laboratory products (clinical chemistry, immunochemistry, coagulation, instrumentation, rapid tests), OEM reagents to the diagnostics industry and over the counter (OTC) products. Charged with distributor acquisition and management, strategic business partnership development, product training or product development for the three different business strategies. 1995 - Present. ROCHE DIAGNOSTIC SYSTEMS, Regional Marketing Manager - Asia, Kuala Lumpur, Malaysia Immunochemistry, Toxicology, Molecular Diagnostics (Polymerase Chain Reaction - PCR) and associated instrumentation. Direct responsibilities are to train customers, distributors, regional Roche personnel, provide technical support, educate and develop the product potential in 9 countries on the Asia-Pacific region. Reporting activity are to three business units, either European, US and the Swiss headquarters point. Measurable success has been directly related to 5 year business and marketing plan development, extensive travel to customer sites, professional medical speakership, product related symposia and trade show organization. Direct reports : 3. 1991 - 1995. ROCHE DIAGNOSTIC SYSTEMS, Immunochemistry Business Unit Marketing Manager, Basle, Switzerland Immunochemistry Instruments and Reagents. Position demanded development of all elements related to product support and introductions on a global basis. Support was internally directed at Roche personnel or distributors to guarantee that sales targets and goals were met to maximize product potential. Direct reports : 7. 1989 - 1991 ABBOTT DIAGNOSTICS DIVISION, Area Strategy Manager - Europe, Middle-East & Africa (EME&A), Wiesbaden, Germany Laboratory Instrumentation and Reagents. Keys to success were formulated strategic plans, pricing, marketing plan development and implementation, as well as promotional efforts throughout EME&A. Position required extensive travel to the Abbott European affiliates to support and conceive local marketing plans and activities - based upon local requirements - and in-line with overall corporate goals and objectives. 1986 - 1989. Previous experience in In-Vitro and In-Vivo (radio-pharmaceutical) diagnostics - DuPont / New England Nuclear - Dreieich, Germany, European Product Manager, 1980 - 1985. Education American University, Washington, DC MBA Candidate Economics/Statistics Widener University, Chester, Pa, - Marketing/Business Management St. Joseph’s University, Phil, PA - B SC Bio-Chemistry Personal Working knowledge of most Microsoft Windows 95 applications (Word, Excel, Powerpoint), IBM (OS2 Internet Connections - Gopher, WWW, email) and Harvard Graphics computer applications related to business management. Have been trained in professional selling skills, marketing and financial management. American citizenship, married, fluent spoken German. References Excellent international professional and personal references can be supplied upon request. World Wide Web http://conquest-prod.iserver.com/jobnetwork/resumesubmit/ messages/1379.html From owner-diagnostics@net.bio.net Sat Jun 29 23:00:00 1996 Path: biosci!bcm.tmc.edu!cs.utexas.edu!swrinde!newsfeed.internetmci.com!in2.uu.net!news.ios.com!news2.ios.com!usenet From: petecoc1@chelsea.ios.com (Cannon) Newsgroups: bionet.diagnostics Subject: Available Medical Imaging Equipment Date: Sun, 30 Jun 1996 14:51:18 GMT Organization: Internet Online Services Lines: 57 Message-ID: <4r5pl0$gu7@news2.ios.com> NNTP-Posting-Host: ppp-4.ts-6.nyc.idt.net X-Newsreader: Forte Free Agent 1.0.82 Cannonclave Inc. 145 Palisade Street, suite 244, Dobbs Ferry, NY 10522 Tel: (914) 693-2771 Fax: (914) 693-3260 We have the following medical imaging equipment in stock and for sale. In Stock! For sale now 1986 General Electric RT 50 $4,000 tiny linier ultrasound machine 3.5 mHz Linier probe. 1979 Polarix ll $5,000 Moble C-Arm single monitor 1986 Philips Diagnost UM $7,500 mamograph with all accessories Biopsy , Mag., ROM-20 .1-.3Tube, All paddles Auto Compression 1985 Picker Hitachi Techmoble $5,500 High power mobile X-ray machine 125 Kv 300 mas 1987 Picker Artis with doppler $7,500 Ultrasound machine with cardiac and PV doppler And the rest of the body. 3.5 sector 3.5 linier 7.5 small parts 8.0 CW doppler 1988 H.P. Sonos 100 a $14,000 Ultrasound for cardiology 2.5 sector 3.5 sector Panasonic VCR 1992 General Electric Sonochrome Colorflow $29,000 Colorflow ultrasound for entire body and Cardioogy All Software 3.75, & 6.0 sector, 7.0 Endocavity, 7.5 Linier, 7.5 Convex 5.0 Endovaginal 1991 Diosonics Spectra Colorflow $25,000 Colorflow ultrasound for everthing but cacrdiology 5.0 spa, 10.0 small pts, 7.5 scla, 3.5 scla, 7.5 Transrectal Contact: Jim Cannon Voice (914) 693-2771 or Fax (914) 693-3260 New telephone and fax numbers!!!! email petecoc1@chelsea.ios.com From owner-diagnostics@net.bio.net Sun Jun 30 23:00:00 1996 Path: biosci!rutgers!uwm.edu!cs.utexas.edu!swrinde!newsfeed.internetmci.com!news.sprintlink.net!news-stk-200.sprintlink.net!news.sprintlink.net!news-dc-10.sprintlink.net!coopnews.coop.net!boulder.earthnet.net!usenet From: James Stiehr Newsgroups: bionet.general,bionet.cellbiol,bionet.cellbiol.cytonet,bionet.diagnostics,bionet.immunology,bionet.molbio.methds.reagnts,bionet.molbio.proteins,bionet.neuroscience Subject: FDA TO REGULATE RESEARCH ANTIBODIES Date: Mon, 01 Jul 1996 09:17:42 -0700 Organization: Affinity BioReagents, Inc. Lines: 21 Message-ID: <31D7FA26.377@bioreagents.com> NNTP-Posting-Host: slip10.earthnet.net Mime-Version: 1.0 Content-Type: text/plain; charset=iso-8859-1 Content-Transfer-Encoding: 8bit X-Mailer: Mozilla 2.0 (Win16; I) Xref: biosci bionet.general:22595 bionet.cellbiol:5021 bionet.cellbiol.cytonet:585 bionet.diagnostics:946 bionet.immunology:9237 bionet.molbio.proteins:8231 bionet.neuroscience:14752 The FDA has just proposed new regulations on the sale and distributions of antibodies and other reagents which will result in the withdrawal of many research reagents from the US market. The net result of these regulations is the reduction of tools available to the US research community (non-US researchers will still have access to these tools). The “Research Use Only” disclaimer WILL NOT prevent the FDA from removing many reagents from the market if suppliers do not treat antibodies as In Vitro Diagnostic Devices, submitting them to FDA for review, approval and oversight. For a more thorough review of the issue as well as the regulations themselves, a special web page has been set up as an educational resource. Visit http://www.earthnet.net/~affinity/fda for an overview of the issues, the proposed regs, and what you can do about them. Protect your access to these critically important research tools! Act today! James Stiehr Affinity Bioreagents, Inc. From owner-diagnostics@net.bio.net Sun Jun 30 23:00:00 1996 Path: biosci!rutgers!uwm.edu!math.ohio-state.edu!howland.reston.ans.net!swrinde!newsfeed.internetmci.com!news.exodus.net!news.zeitgeist.net!news1.slip.net!news From: Tom@firstenberg.com (Tom) Newsgroups: bionet.diagnostics,sci.bio.technology,sci.chem.labware Subject: PCX Pollution Control Evaporator Date: Mon, 01 Jul 1996 20:34:40 GMT Organization: Firstenberg Machinery Lines: 11 Distribution: inet Message-ID: <4r9d2c$nja@news1.slip.net> NNTP-Posting-Host: 206.14.14.214 X-Newsreader: Forte Free Agent v0.55 Xref: biosci bionet.diagnostics:947 sci.bio.technology:5647 sci.chem.labware:2254 There is available for immediate sale an R.P.R. PCX-50 F pollution control system. Unit takes any combination of aqueous based developer,fixer,rinse water or similar liquid and pumps into evaporator where chemistry is heated and electronically controlled draft inducer draws off evaporated water and vents it harmlessly into air. Remaining material is concentrated and filtered for disposal. Call for details and pricing at 510-233-7777 or fax at 510-236-9685 or email. Tom@firstenberg.com